Description
<p ><b >DESCRIPTION<o:p></o:p></b></p>
<p ><b >Volume 1<o:p></o:p></b></p>
<p >Edition: 2003 </p>
<p ><o:p> </o:p></p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >It is being globally recognized that medicinal plants play a
significant role in providing health benefits to human beings. The increase in
the demand for plant based medicines and their eventual commercialization has
brought about a major shift in their status from providing strictly
individually tailored hand picked plant products based health care to availability
of over the counter health products. But global acceptance of Indian
plant-based drugs is still low. Non-availability and/or inadequacy of quality
standards is perhaps the single most important factor responsible for it.
International agencies like World Health Organization (WHO), United Nations
Industrial Development Organisation (UNIDO), International Centre for Science
and High Technology (ICS) and Asia Pacific Centre for Transfer Technology
(APCTT) have also emphasized on the need of ensuring quality control of
medicinal plant drugs by applying suitable standards employing modern
techniques. But this is unlikely to be achieved until the quality of the base
material for formulating the herbal products is assured. The complex
composition of medicinal plant drugs, has posed a major challenge for quality
control.</p>
<p ><o:p> </o:p></p>
<p >Standardization of the presumed active constituents of the
drug is perhaps not the best approach; as only in few cases does the
drug-activity depend upon a single component. In fact, it is the outcome of
synergistic effect of several active compounds and accompanying inert
substances. It is thus, reasonable to use the naturally occurring wholesome
medicinal plant material for standardization. A number of factors such as age
and origin of the plant, time of its collection, method of drying, garbling,
storage etc. influence the proportion of various components in the plant
material. The analytical limits therefore, cannot be expected to be as precise
as for the single pure synthetic drug.</p>
<p >Inspite of these and other inherent difficulties, quality
standards for the medicinal plants used in India are necessary for the drugs
and formulations produced from them to be of adequate quality, safety and
efficacy for their wide acceptance.</p>
<p >In response to this need, the Indian Council of Medical
Research has taken the initiative to lay down quality standards of important
medicinal plants, as per WHO guidelines. Reputed institutes have been involved
to evolve these standards. Vital has resulted in the production of this volume,
which is first in the series and deals with 32 medicinal plants. I trust this
volume will be of immense help to medicinal plant based data generated at these
institutes and compilation of the requisite information from literature drug industry,
drug analytical laboratories, drugs control authorities, academicians and
researchers engaged in work on medicinal plant drugs.</p>
<p >I deeply appreciate the efforts of the Chairman and the
members of the various Committees viz., Scientific Advisory Group, the Task
Force, the Technical Review Committee. The work would not have been possible
but for the important role played by the collaborative Institutions.</p>
<p >Despite certain limitations that these standards may have,
it is a step towards improving the quality of finished product. Better quality
would inevitably help in raising the acceptance of Indian plant based health
products.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >Interest in medicinal plants has been overwhelming in the
recent times especially as an important source of medication/health care in
Indian Systems of Medicine. Currently, the global market for medicinal plants
has been estimated around US $62 billion and the demand is growing rapidly.
While, the domestic trade in herbal drug preparations used in Indian Systems of
Medicine is to the tune of Rs. 4200 crores per annum, the annual export from
India to the tune of Rs. 400 crores only.</p>
<p >In our country nearly 7,500 plant species are being used in
the formulation of medicinal plant-based health care products. The quality and
the efficacy of these preparations depend largely on the quality of the raw
material used. The increase in the reported incidence of toxicity,
indiscriminate use and easy availability of herbal preparations and food
supplements makes it imperative to lay down standards which could ensure their
quality, safety and efficacy. Our plant based drug industry too needs quality
parameters for medicinal plants for the production of quality ensured
standardized herbal drugs.</p>
<p ><o:p> </o:p></p>
<p >Evolving methods of standardization and establishing quality
control parameters for herbal drugs calls for a well planned approach for
establishing standards and this can be achieved only through systematic
evaluation of the plant material using modern analytical techniques including
chromatographic ones.</p>
<p >With this background, the ICMR took an initiative for
development of standards of selected medicinal plants commonly used in India
for their therapeutic value. A Task Force was constituted, list of plants drawn
and the work was carried out at four institutions viz., B.Y. Patel
Pharmaceutical Education and Research Development Centre, Ahmedabad; National
Botanical Research Institute, Lucknow; National Institute of Pharmaceutical
Education and Research, S.A.S. Nagar (Mohali) and Tropical Botanic Garden and
Research Institute, Thiruvanthapuram. The work done at these institutes has
resulted in preparation of monographs on 32 plants encompassing detailed
pharmacognostic and phytochemical studies coupled with other information based
on literature review.</p>
<p >The publication is the first volume in the series on
standards of medicinal plants and is expected to be useful for the herbal drug
industry/pharmacies, practitioners of indigenous systems of medicine,
academicians, researchers and health professionals. The regulatory authorities
may also find it useful as a reference. Preparation of the second volume in the
series is in progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Plant based medicines have been used by mankind since time
immemorial. According to the report of World Health Organization, over 80 per
cent of the world population relies on the traditional systems of medicine,
largely plant based, to meet their primary health care. The effectiveness of
these systems, in turn, mainly depends upon the proper use and sustained
availability of genuine raw material. Global resurgence of the interest in
herbal drugs has led to the need of their mass production which perhaps was not
even contemplated by the traditional medicine practitioners who prepared and
dispensed the medicine on a personal and individual basis. Largescale
production of medicinal plant products necessitated the availability of
standards to ensure their quality, efficacy and safety.</p>
<p >Furthermore, limited availability of medicinal plants of
consistent quality has been perhaps one of the toughest impediment for reliable
biological, pharmacological, chemical and clinical evaluation besides their use
in health care. Lack or inadequacy of quality standards has been a discouraging
factor for many potential herbal drug manufacturers and also a handicap in
regulating the herbal drug market.</p>
<p >Against this backdrop, the Indian Council of Medical
Research initiated a programme for laying down quality standards of about 200
medicinal plants widely used in India. Special emphasis has been laid on
various chromatographic techniques including thin layer chromatographic,
fingerprinting, HPTLC, HPLC, and GLC wherever needed. The studies complemented
by literature backup has resulted in the preparation of monographs on 32
individual medicinal plants which have been covered in the present first
volume. The work on the remaining plants is in progress.</p>
<p >The contents of monograph on each plant have been
systematically described as follows:</p>
<p >Botanical name with authority, synonym, part(s) used,
geographical source.</p>
<p ><o:p> </o:p></p>
<p >Other names of the drug in different languages.</p>
<p >Part(s) of the plant used as drug.</p>
<p >Macroscopic and microscopic description of the drug with
special emphasis on diagnostic characters of the part(s) used along with colour
photographs of the plant, part(s) used and illustrated diagrams of histological
features.</p>
<p >Chemical constituents, structure of important chemical
constituents. Identity test based on different chemical groups and TLC / GLC
fingerprint profiles along with marker compound(s).</p>
<p >Assay/analytical method (using HPLC, HPTLC, GLC etc.) for
the analysis of marker compounds along with detailed procedure and
chromatograms.</p>
<p >Other quantitative standards include foreign matter, total
ash, acid-insoluble ash, ethanol-soluble extractive, water-soluble extractive
and loss on drying.</p>
<p >Adulterants/substitutes if any, giving details of
distinguishing features from the genuine drug.</p>
<p >Important pharmacological and clinical studies in brief, as
reported in the literature.</p>
<p >Therapeutic category as mentioned in Ayurvedic texts or as
evidenced by clinical trials and reported in literature.</p>
<p >Safety aspects as mentioned in Ayurvedic texts or as
reported in publications on pharmacological/toxicological aspects.</p>
<p >Dosage as mentioned in Ayurvedic texts or as reported in
other scientific publications.</p>
<p >Complete references of the work cited.</p>
<p >This is followed by relevant appendices giving methods for
evaluation of crude drugs (appendix I), phytochemical evaluation of raw
material (appendix II), methods for isolation of markers (appendix III), drying
and storage of raw material (appendix IV), pesticides, residues and microbial
contamination (appendix V) and plant allocated to various institutions
(appendix VI). Indices on botanical names, chemical constituents and other names
of plants have been given at the end.</p>
<p ><o:p> </o:p></p>
<p ><span > </span></p>
<p ><o:p> </o:p></p>
<p ><o:p> </o:p></p>
<p ><o:p> </o:p></p>
<p ><b >Volume 2<o:p></o:p></b></p>
<p >Edition: 2005</p>
<p ><o:p> </o:p></p>
<p ><b ><span
> </span>Foreword<o:p></o:p></b></p>
<p >There has been global resurgence' of interest in the area of
medicinal plant health care products, as a result of which, a number of
national and international organizations such as World Health Organization,
European Scientific Cooperative, German Commission E, Japanese and Chinese
organizations, have taken initiative to prepare and publish monographs on
medicinal plants. All such monographs lay special emphasis on quality standards
of the plant material. India is one of the twelve mega biodiversity centres
rich in medicinal and aromatic plants occurring in diverse ecosystems. Out of
the 45,000 known plant species nearly 1500 plant species are being used in the
Indian System of Medicine. In the draft of the National policy on the Indian
System of Medicine, priority is being given to research on standardization
besides pharmacology, toxicology and clinical trials of herbal drugs.</p>
<p >The Indian Council of Medical Research took initiative to
lay down quality standards of important medicinal plants involving reputed
research institutes. The collection of monographs published in 2003 as
"Quality Standards of Indian Medicinal Plants Vol. 1" was the outcome
of these efforts. The current publication is the second volume of the above
series. We are happy to note that the first volume was greatly appreciated and
received well by all those involved in different activities related to herbal
drugs in India and abroad. I hope that just like the first volume, the second
volume will also be of great help to medicinal plant based drug industry, drug
regulatory authorities, researchers and academicians involved in work on
medicinal plants.</p>
<p >I greatly appreciate the efforts of the Chairman and the
members of the Scientific Advisory Group, Task Force and the Technical Review
Committees and the contributions made by the participating institutions.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >Worldwide interest in multifaceted potential of plants has
resulted into gradual transition of the traditional medicine from being a
personalized one to the present state where the plant based drugs are
commercially produced in large scale and sold as OTC drugs or as prescription
medicines. Furthermore in India where almost 90 percent of the raw material for
herbal medicinal products is procured by the industry from wild sources, there
is every possibility of vast variation of chemical constituents in the material
collected from different geographical sources. In addition there is a
possibility of deliberate adulteration or substitution in the genuine raw
material. In such a scenario proper quality control of the herbal raw material
as well as finished products becomes essential. Thus, the need for development
of quality standards and preparation of monographs there on, cannot be over
emphasized.</p>
<p ><o:p> </o:p></p>
<p >In an effort to address this problem, the Indian Council of
Medical Research initiated a programme on evolving standards for the medicinal
plants involving reputed research institutes in the country. Under this programme
the first volume of "Quality Standards of Indian Medicinal Plants"
covering 32 plants was published in 2003. This is the second volume in the
series and contains quality standards of another set of 32 medicinal plants. As
with the first volume, the second volume in the series is also expected to be
well received and useful to the herbal drug industry, practitioners of
Indigenous System of Medicine, academicians, researchers and health
professionals including regulatory authorities.</p>
<p >Preparation of the third volume in the series is in
progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >World Health Organization promotes and encourages the use of
herbal medicinal products in the national health care programmes of various
countries as 3/4th of the world population relies on traditional systems of
medicine, largely medicinal plant based, to meet their primary health care
needs. Lack of or inadequacy of quality standards of the herbal material has
been an impediment in the wider acceptance of the herbal medicinal products as
well as a discouraging factor for many reputed herbal drug manufacturers and
also a handicap in regulating herbal drug market. In an effort to address this
problem, the Indian Council of Medical Research initiated work on the
preparation of standards for herbal raw material involving several reputed
research institutes in the country. This endeavour resulted in publication of
the first volume on "Quality Standards of Indian Medicinal Plants" in
2003. In continuing efforts in this direction, this is the second volume in the
series containing monographs on the raw material from 32 medicinal plants. The
approach being followed for executing this work is as follows:</p>
<p >Authentic plant material is procured from three geographical
locations. Details of pharmacognostic features, quantitative standards and
phytochemical profiles are generated by the participating institutions.
Information on the distribution of the plants, vernacular names, chemical
constituents, pharmacological activity, adulterants/substitutes, therapeutic
claims, safety aspects and dosage is derived from the published literature and
classical books. Literature search for each plant is made, reviewed and only
the relevant information is incorporated from original articles.</p>
<p >From the information so generated, each monograph is
compiled, and presented in a uniform format, under the following heads:</p>
<p >The monograph starts with the part used, botanical name with
authority, synonyms and distribution of the plant.</p>
<p ><b >Other Names</b>:
Include vernacular names of the drug (part of the plant that is being used) in
different regions of the country.</p>
<p ><b >Description</b>:
Contains macroscopy and microscopy of the drug with special emphasis on
diagnostic characteristics, organoleptic examination of the raw material as
well as its powder and illustrated figures and photographs are also given.</p>
<p ><o:p> </o:p></p>
<p >Chemical Constituents: The structures of important compounds
and active principles (if known) are given. While making the structures of the
chemical constituents, stereochemistry is also taken into consideration
wherever information on stereochemistry of specific compounds is available. The
chemical constituents are listed under two sub heads, viz., major and others.
Under the former category, the chemical constituents which are either present
in significant amount in the drug or are important from the activity point of
view (active principle of the drug), even if present in relatively small
amounts are given. Under the second category of chemical constituents which are
present in small amount or their contribution towards the activity of the drug
is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles have
been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability. As far as
possible, fingerprint profiles are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Detailed description for the
analysis of marker compound is given. In certain cases, chemical groups are
estimated, e.g., total alkaloids, total hydroxyanthracene derivatives, etc. In
all the cases, sample preparation is optimized to enable complete extraction of
compounds of interest.</p>
<p >Quantitative Standards: Extractive values and ash values are
derived by employing standard methodology and techniques as given in the Indian
Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO guidelines for Quality
Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Information is provided whereever
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original published articles in journals of
repute. Clinical trials, wherever conducted have been mentioned.</p>
<p >Major Therapeutic Claims: These are derived from classical
texts of Ayurveda with appropriate references and also other standard
publications or evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
mentioned with appropriate references. If no specific toxicity is reported, it
is considered to be safe in the dose traditionally used.</p>
<p >Dosage: Is taken from the standard Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the histology of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >Relevant appendices are added at the end of the volume,
giving methods for the evaluation of the crude drugs (Appendix I),
phytochemical evaluation of raw material (Appendix II), methods for isolation
of markers (Appendix III), drying and storage of raw material (Appendix IV),
pesticide residues and microbial contamination (Appendix V) and plants
allocated to various institutes for development of quality standards (Appendix
VI). Indices on botanical names, chemical constituents and names of plants in
other languages have been given at the end.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 3<o:p></o:p></b></p>
<p >Edition: 2005</p>
<p ><o:p> </o:p></p>
<p >Foreword</p>
<p >Man's dependence on plants for health care is as old as the
existence of the mankind on this planet. Since the advent of modern medicine,
plants have also become a source of important phytopharmaceuticals and lead
molecules with unique chemical structures and mechanism of action. Over the
last few decades alternative medicine, which is essentially plant based, has
experienced a remarkable and steady increase all over the world. This has
generated a multifaceted interest in the medicinal plants, which includes the
sourcing of the raw material (through cultivation or from wild populations),
preparation of formulations, multimarker based phytochemical evaluation for
standardization, pharmacological, toxicological and clinical evaluation to
establish efficacy and safety, of single drugs as well as polyherbal
formulations and their large scale manufacture and marketing. This activity has
necessitated the requirement of good quality of raw material. Consequently it
became important to establish quality parameters for the herbal raw material.
In the recent years many national and international bodies have been preparing
and publishing monographs on medicinal plants defining quality parameters
necessary to maintain quality.</p>
<p >In India, with its age old traditional systems of medicine
and rich treasure of medicinal plants, about 1500 plant species are being used
in the Indian System of Medicine, and many more plants in the folk and tribal
medicine. The Indian Council of Medical Research took initiative to lay down
standards for herbal raw material from important medicinal plants, involving
reputed research institutes of India. An outcome of these efforts has been the
publication of two volumes of monographs on the "Quality Standards of
Indian Medicinal Plants". The current publication is the third volume of
this series. The first two volumes received the appreciation of all those
involved in different activities related to medicinal plants, We hope that the
third volume also will be received well and be of help to herbal drug industry,
drug regulatory authorities, researchers and academicians. I greatly appreciate
the efforts of the Chairman and members of the Scientific Advisory Group, the
Task Force, the Technical Review Committee, investigators and the research
institutions which contributed to the significant task of developing quality
standards.</p>
<p ><o:p> </o:p></p>
<p ><span > </span></p>
<p ><b >Preface<o:p></o:p></b></p>
<p >The interest in and the demand for the plant based drugs
increased in the last few decades, and this led to large scale commercial
production of both classical and proprietary herbal formulations in the
country. As a result, the demand for herbal raw material also increased. The
raw material is being procured from wild as well as cultivated sources. Several
factors are known to influence the quality of the herbal raw material. Hence,
to maintain quality and to ensure efficacy, quality parameters are to be
defined.</p>
<p >Sensing this need, the Indian Council of Medical Research initiated
a programme to develop monographs on important Indian medicinal plants
involving several research institutes and laboratories of the country. The
monographs so evolved are being published under a series. So far two volumes of
"Quality Standards of Indian Medicinal Plants" have been published
which contain monographs on 32 medicinal plants each. This is the third volume
in the series with monographs on 40 medicinal plants. We expect these
monographs to be of use to the herbal drugs manufacturers, regulatory
authorities, academicians, researchers and those interested in medicinal
plants.</p>
<p >Work on preparing monographs on raw materials from many more
medicinal plants is in progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Multifaceted potential of medicinal plants, as also the fact
that about three fourth of the world population relies on traditional systems
of medicine to meet their primary health care needs, has generated a global
interest in the area of medicinal plants. Various international agencies like
World Health Organization have been emphasizing on the importance and need of
standardization of herbal raw material. Lack of or an inadequate quality
standard of raw material has been one of the major impediments in wider
acceptance of herbal drugs. It has also been a discouraging factor for many
herbal drug manufacturers besides being a handicap in regulating herbal drug
market. In an effort to address this problem, the Indian Council of Medical
Research initiated work on the preparation of standards for herbal raw material
involving several reputed research institutes in the country. This endeavour
resulted in publication of the two volumes on "Quality Standards of
Medicinal Plants". In continuing efforts in this direction, this is the
third volume in the series containing monographs on the raw material from 40
medicinal plants. The approach being followed for executing this work is as
follows:</p>
<p >Authentic plant material is procured from three geographical
locations. Details of pharmacognostic features, quantitative standards and
phytochemical profiles are generated by the participating institutions.
Information on the distribution of the plants, vernacular names, chemical
constituents, pharmacological activity adulterants/substitutes, therapeutic
claims, safety aspects and dosage is derived from the published literature and
classical books. Literature search for each plant is made, reviewed and only
the relevant information is incorporated from original articles.</p>
<p ><o:p> </o:p></p>
<p >From the information so generated, each monograph is
compiled, and presented in a uniform format, under the following heads:</p>
<p >The monograph starts with the part used, botanical name with
authority, synonyms, geographical source and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug in
different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: The chemical constituents are listed
under two sub heads, viz.; major and others. Under the former category, the
chemical constituents which are either present in significant amount in the
drug or are important from the activity point of view (active principle of the
drug), even if present in relatively small amounts are given. Under the second
category, the chemical constituents which are either present in small amount or
their contribution towards the activity of the drug is not known, are listed.
The structures of important compounds and active principles (if known) are
given. While making the structures of the chemical constituents,
stereochemistry is also taken into consideration wherever information 0
specific compounds is available.</p>
<p >Identity Tests: Chromatographic fingerprint profiles have
been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability. TLC is
found to be practically more feasible and suitable to resolve most of the
components of the extract under study. As far as possible, fingerprint profiles
are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Detailed description for the
analysis of marker compound is given. In certain cases, chemical groups are
estimated, e.g., total alkaloids, etc. In all the cases, sample preparation is
optimized to enable complete extraction of compounds of interest.</p>
<p >Quantitative Standards: Extractive values and ash values are
derived by employing standard methodology and techniques as given in the Indian
Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO guidelines for Quality
Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Information is provided where ever
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original published articles in journals of
repute. Clinical trials, wherever conducted have been mentioned.</p>
<p ><o:p> </o:p></p>
<p >Major Therapeutic Claims: These are derived from classical
texts of Ayurveda with appropriate references and also other standard
publications or evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
mentioned with appropriate references. If no specific toxicity is reported, it
is considered to be safe in the dose traditionally used.</p>
<p >Dosage: Is taken from the standard Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >Relevant appendices are added at the end of the volume,
giving methods for the evaluation of the crude drugs (Appendix I),
phytochemical evaluation of raw material (Appendix II), methods for the isolation
of markers (Appendix III), drying and storage of raw material (Appendix IV),
pesticide residues and microbial contamination (Appendix V) and plants
allocated to various institutes for development of quality standards (Appendix
VI). Indices on botanical names, chemical constituents and other names of the
plants have been given at the end.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 4<o:p></o:p></b></p>
<p >Edition:2006</p>
<p ><o:p> </o:p></p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >The growing worldwide interest in medicinal plants and fast
expanding global market in the last two decades, has necessitated for quality
ensured herbal drugs. Further, the increase in the incidence of toxicity
reported due to the indiscriminate use of herbal preparations available over
the counter and as food supplements make it important to ensure their safety
and efficacy. Therefore, in the present business and industrial scenario, and
considering the interest and faith that people have on herbal products, the
need for their standardization cannot be over emphasized. The safety and
efficacy of herbal preparations depend largely on the quality of the raw
material used.</p>
<p >In this backdrop, ICMR took initiative in evolving quality
standards for plants most widely used as raw material in Indian systems of
medicine, especially those of Ayurveda. Several reputed institutions are
involved in this endeavour. The efforts have so far resulted in bringing out
three volumes of Quality Standards of Indian Medicinal Plants carrying
monographs on 104 plants. The current publication with Monographs on 32 plants
is fourth in the series. I do hope the present volume shall also be received
well with all those concerned with medicinal plants. The commendable efforts
and co-operation of the Chairman and the members of Scientific Advisory Group,
the Task Force, the Technical Review Committee as also the investigators and
the research institutions in bringing out this publication are appreciable.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >Medicinal plants constitute one of the richest bioresource
for herbal drugs, food supplements, natural cosmetics, complimentary alternate
medicines, phytoconstituents of industrial significance and lead molecules for
the development of Allopathic drugs. A number of countries including Germany,
France, Canada, USA, China, etc. are registering standardized medicinal plant
extracts of proven clinical efficacy and safety as herbal drug preparations or
food supplements. Inspite of the fact that India has a vast resource of
medicinal plants, we are unable to exploit the growing world market to the
required extent because we do not have a very satisfactory system of their quality
control and registration. Therefore, it becomes absolutely essential to have
quality standards of the raw material.</p>
<p >In this direction, in the year 2000 the ICMR initiated work
on quality standards of Indian medicinal plants, involving laboratories of
reputed institutes of the country. Three volumes of "Quality Standards of
Indian Medicinal Plants" covering standards of 104 medicinal plants have
already been published. We expect that this fourth volume like the earlier
three volumes will also be of interest to the herbal drug industry,
practitioners of the Indigenous Systems of Medicine, academicians, researchers,
health professionals and regulatory authorities.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >In the National Policy on the Indian Systems of Medicine
(ISM) by the Department of A YUSH, priority is being given to research on
standardization, pharmacology, toxicology and clinical trails of ISM drugs. In
all these studies one important common factor, which can be called the
lifeline, is the quality, especially of the raw material, and the crux is the
inavailability of methods for the quality assessment.</p>
<p >Currently, the herbal drug preparation itself is regarded as
the active substance. Hence the reproducibility of the total configuration of
herbal drug constituents is important, and the TLC/GLC/ HPLC fingerprint
profiles will serve as guiding line to the phytochemical profile of the drug in
ensuring the quality, while quantification of the marker compound/s would serve
as an additional parameter in assessing the quality of the sample.</p>
<p >As a part of its ongoing programs, Medicinal Plants Unit of
the Indian Council of Medical Research has been bringing out a series of
publications on the quality standards of important medicinal plants used in the
traditional medicine. This is the fourth volume in the series, "Quality
Standards of Indian Medicinal Plants" containing 32 monographs. Several
national institutions have been participating in this national endeavour and
just as in the first three volumes, the following guidelines have been adopted
in evolving the standards for the plants included in this volume.</p>
<p >The raw material of the plants is procured from the field,
from at least three different geographical locations and authenticated. The
samples are worked out for their pharmacognostic and phytochemical features
through experiments while the information on the distribution of the plants,
vernacular names, chemical constituents, pharmacological activity, safety
aspects, clinical studies if any, therapeutic claims and any other details are
derived from the published literature and compiled in the form of a monograph,
along with complete references of the work cited. The results of experiments
conducted and the compiled data are subjected to careful scrutiny by the
experts of the Technical Review Committee.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >The monograph starts with the part used, botanical name with
authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: The chemical constituents are listed
under two sub heads, viz., major and others. Under the former category, the
chemical constituents which are either present in significant amount in the
drug or are important from the activity point of view (active principle of the
drug), even if present in relatively small amounts are given. Under the second
category, the chemical constituents which are either present in small amount or
their contribution towards the activity of the drug is not known, are listed.
As far as possible the chemical constituents are grouped together on the basis
of clan of compounds. The structures of important compounds and active
principles (if known) are given. While making the structures of the chemical
constituents, stereochemistry is also taken into consideration wherever
information on stereochemistry of specific compounds is available.</p>
<p >Identity Tests: Chromatographic fingerprint profiles have been
generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability. TLC is
found to be practically more feasible and suitable to resolve most of the
components of the extract under study. As far as possible, fingerprint profiles
are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Detailed description for the
analysis of marker compound is given. In certain cases, chemical groups are
estimated. In all the cases, sample preparation is optimized to enable complete
extraction of compounds of interest.</p>
<p >Quantitative Standards: Extractive values and ash values are
derived by employing standard methodology and techniques as given in the Indian
Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO guidelines for Quality
Standards of Medicinal Plants.</p>
<p ><o:p> </o:p></p>
<p >Adulterants/Substitutes: Information is provided wherever
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original research articles published in journals
of repute. Clinical trials, wherever conducted have been mentioned.</p>
<p >Major Therapeutic Claims: These are derived from classical
texts of Ayurveda with appropriate references and also other standard
publications or evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
mentioned with appropriate references. If no specific toxicity is reported, it
is considered to be safe in the dose traditionally used.</p>
<p >Dosage: Is taken from the standard Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and / or camera
lucida diagrams of the sections of the drug, and TLC fingerprint details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first three volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix T), phytochemical evaluation (Appendix II),
methods for the isolation of markers (Appendix Ill), methods of drying and
storage of raw material (Appendix IV), limits of pesticide residues and
microbial contamination (Appendix V) and plants allocated to various institutes
for preparing the monographs (Appendix VI). The appendices section is followed
by indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 5<o:p></o:p></b></p>
<p >Edition:2008</p>
<p ><o:p> </o:p></p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >Resurgence of interest in the medicinal plants and their
products all over the globe is evident from the rising figures of trade and
marketing as well as extensive and intensive scientific publications in the
national and international journals. In such a rising global market trend and
scientific awareness of medicinal plant products, there exist many fold
opportunities in various segments such as traditional medicines, home remedies,
nutraceuticals, phytopharmaceuticals, natural drug molecules, gums, mucilages,
natural dyes, insect repellants, insecticides, pesticides etc. There are a
number of challenges in sustainable industrial exploitation of medicinal plants
bioresource for all the segments mentioned. One of the major challenges is
inadequacy of quality standards available for producing and maintaining quality
and consistency of medicinal plant products. The Indian Council of Medical
Research initiated the programme of developing quality standards of Indian
medicinal plants in the year 2002. This endeavour yielded very fruit results
evidenced by the publication of four volumes of Quality Standards of 136
medicinal plant. Under this continuing programme, this fifth volume comprising
quality standards of another 34 Indian medicinal plants is being published.
It's a commendable national effort at the appropriate time in the right
direction. These quality standards will be of great help to all those engaged
in developing various quality products from Indian medicinal plants.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >The medicinal plants have not only been known to be the
backbone of all systems of medicine but have been finding extensive place in
household remedies, nutraceuticals and cosmetics. In view of the wider acceptance
of medicinal plant based products and fast expanding market globally, the
quality of the raw material used particularly in the herbal drugs assume
special significance in context of experimental studies, clinical trials and
therapeutics. Further, the TLC/GLCIHPLC fingerprint profile, as also
quantification of the marker compound serve as guiding line to the
phytochemical profile of the drug in ensuring the quality.</p>
<p >Medicinal Plants Unit of the Indian Council of Medical
Research has been instrumental in developing quality standards of medicinal
plants through participation of various reputed institutions, and bringing out
a series of publication entitled "Quality Standards of Indian Medicinal
Plants". The present volume is 5th in this series and contain monographs
on 34 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p ><o:p> </o:p></p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.;
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category of other chemical
constituents which are in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability. TLC is
found to be more practically feasible and suitable to resolve most of the
components of the extract under study. As far as possible, fingerprint profiles
are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the analysis
of marker compound. In certain cases, chemical groups are estimated. In all the
cases, sample preparation is optimized to enable complete extraction of
compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is available
and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original published articles in journals of
repute. Clinical trials, wherever conducted have been mentioned.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug is
mentioned with appropriate references. If no specific toxicity is reported, it
is considered to be safe in the dose traditionally used.</p>
<p ><o:p> </o:p></p>
<p >Dosage: Is taken from the Standard Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first four volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II), methods
for the isolation of markers (Appendix III), methods of drying and storage of
raw material (Appendix IV), limits of pesticide residues and microbial
contamination (Appendix V) and plants allocated to various institutes for
preparing the monographs (Appendix VI). The appendices section is followed by
indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 6<o:p></o:p></b></p>
<p >Edition: 2008</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >There has been global emphasis on the importance of
standardization of herbal drugs particularly for delivering improved health
care. The need for standardization has been recognized time and again world
over at different global forums by various national and international agencies
including WHO. Inadequacy or lack of standardization of raw material has been
one of the most constraining factors in our ability to exploit the fast growing
world market of herbal drugs to the required extent, despite India being
credited with unique heritage of abundant biodiversity. These plant based drugs
would be much more widely used nationally and internationally, with wider
acceptance, for enhanced health care if the standardization provides
creditability to the quality of the medicine used, In the time to come, only
those countries with well established standards of herbal drugs can hope to
exploit the worldwide growth in the use of herbal products.</p>
<p >It becomes imperative, therefore to have quality standards
of the raw material used in various plant based products.</p>
<p >The Council's initiative to develop Quality Standards of
Indian medicinal plants with major focus on diagnostic features,
chromatographic profile, markers and overview of multidisciplinary
information/data, shall be of importance and relevance for the herbal drug
industry, researchers, health professionals, regulatory authorities, policy
makers and others interested in the area of medicinal plants, The initiative
may eventually help in development of quality assured safe herbal drugs for
health care.</p>
<p ><o:p> </o:p></p>
<p ><span > </span><b style='mso-bidi-font-weight:
normal'>Preface<o:p></o:p></b></p>
<p >The medicinal plants have not only been known to be the
backbone of all systems of medicine but have been finding extensive place in
household remedies, nutraceuticals and cosmetics. In view of the wider
acceptance of medicinal plant based products and fast expanding market
globally, the quality of the raw materials used in the herbal drugs assumes
special significance particularly in context of conducting experimental
studies, clinical trials and their therapeutic value.</p>
<p >In this backdrop, the Medicinal Plants Unit of ICMR took
initiatives in the year 2000 for developing Quality Standards of medicinal
plants for more widely used raw materials. Several reputed institutions were
involved.</p>
<p >The monographs are on the pattern of WHO guidelines and
incorporate the diagnostic features, phytochemical studies including marker
compound, information on pharmacological, clinical, toxicological aspects,
dosage, adulterants/substitutes etc. The fingerprint profile (TLC/GLCIHPLC), as
also quantification of the marker compound may serve as guiding line to the
phytochemical profile of the drug in ensuring the quality.</p>
<p >As part of this initiative, 5 volumes incorporating Quality
Standards of 170 medicinal plants have been published. The present volume is
6th in this series and contains quality standards of another 35 plants. These
monographs are outcome of the ICMR programme carried out at Agharkar Research
Institute, Pune; BV Patel Pharmaceutical Education and Research Development
Centre, Ahmedabad; Captain Srini vasa Murti Drug Research Institute for Ayurveda,
Chennai; Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal and
National Botanical Research Institute, Lucknow.</p>
<p >It is hoped that the current volume like the previous
volumes shall be useful to all those concerned with medicinal plants and their
products.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw materials involving
several research institutes of Country to address this problem. This programme
has resulted in publication of five volumes on "Quality Standards of
Indian Medicinal Plants" covering 170 plants. The present volume is 6th in
this series and contains monographs on 35 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p ><o:p> </o:p></p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic details,
the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part/s used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination of
the raw material as well as its powder, Illustrated figures and photographs are
also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.;
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category of other chemical
constituents which are in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p ><o:p> </o:p></p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original published articles in journals of
repute. Clinical trials, wherever conducted have been mentioned.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug is
mentioned with appropriate references. If no specific toxicity is reported, it
is considered to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the Standard Ayurvedic texts or from
literature, if published. The monograph is supported by colour photographs of
the plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first five volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II),
methods for the isolation of markers (Appendix ill), methods of drying and
storage of raw material (Appendix IV), limits of pesticide residues and
microbial contamination (Appendix V) and plants allocated to various institutes
for preparing the monographs (Appendix VI). The appendices section is followed
by indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 7<o:p></o:p></b></p>
<p >Edition: 2008</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >In recent years, the worldwide interest in herbal products
has grown significantly particularly for delivering improved health care. With
an increasing global demand for herbal medicines, it is necessary that the
quality and the consistency of these drugs is maintained for their maximal
efficacy. Inadequacy or lack of standardization of raw materials has been one
of the most constraining factors in our ability to exploit the fast growing
world market of herbal drugs to the required extent, despite India being
credited with unique heritage of abundant biodiversity. These plant based drugs
would be much more widely used both nationally and internationally, with wider
acceptance, for enhanced health care if the standardization provides
creditability to the quality of the medicine used.</p>
<p >It becomes imperative, therefore to have quality standards
of the raw material used in various plant based products.</p>
<p >The council's initiative to develop Quality Standards of
Indian Medicinal Plants with major focus on diagnostic features, chromatographic
profiles, markers and overview of multidisciplinary information/data, shall be
of importance and relevance for the herbal drug industry, researchers, health
professionals, regulatory authorities, policy makers and others interested in
the area of medicinal plants. The initiative may eventually help in development
of quality assured safe herbal drugs for health care.</p>
<p >I deeply appreciate the efforts of the Chairman, the members
of the Scientific Advisory Group, the Task Force, the Technical Review Committee,
investigators and the research institutes who have contributed to the
significant task of developing quality standards.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >The medicinal plants have not only been known to be the
backbone of all systems of medicine but have been finding extensive place in
household remedies, nutraceuticals, phytochemicals, natural drug molecules,
gums, mucilages, natural dyes, insecticides, pescticides and cosmetics. In view
of the wider acceptance of medicinal plant based products and fast expanding
market globally, the quality of the raw materials used in the herbal drugs
assumes special significance particularly in context of conducting experimental
studies, clinical trials and their respective therapeutic value.</p>
<p >In this backdrop, the Medicinal Plants Unit of ICMR took
initiatives for developing Quality Standards of Medicinal Plants for more
widely used raw materials. Several reputed institutions were involved.</p>
<p >The monographs are on the pattern of WHO guidelines and
incorporate the diagnostic features, phytochemical studies including marker
compound, information on pharmacological, clinical, toxicological aspects,
dosage, adulterants/substitutes etc. The fingerprint profile (TLC/GLC/HPLC), as
also quantification of the marker compound may serve as guiding line to the
phytochemical profile of the ensuring the quality.</p>
<p >As part of this initiative, 6 volumes incorporating Quality
Standards of 205 medicinal plant have been published. The present volume is
T" in this series and contains quality standards of another 34 plant .
These monographs are outcome of the ICMR programme carried out at Agharkar
Research Institute, Pune; BV Patel Pharmaceutical Education and Research
Development Centre, Ahemdabad; Captain Srinivas Murti Drug Research Institute
for Ayurveda, Chennai; Centre for Medicinal Plants Research, Arya Vaidya Sala,
Kottakkal and National Botanical Research Institute, Lucknow.</p>
<p ><o:p> </o:p></p>
<p >We hope that the current volume like the earlier six volumes
shall be useful to all those concerned with medicinal plants and their products.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw' materials involving
several research institutes of the country to address this problem. This
programme has resulted in publication of six volumes on "Quality Standards
of Indian Medicinal Plants" covering 205 plants. The present volume is
T" in this series and contains monographs on 34 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.;
major and others. Under the former category, the chemical constituents which
are either present in, significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts are given. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p ><o:p> </o:p></p>
<p >Identity Tests: Chromatographic fingerprint profile which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC i found to be more practically feasible and suitable to resolve mo t of the
components of the extract under study. A far as possible, fingerprint profiles
are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing feature is cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological activities
of the part of the plant described as drug. The information is derived in
majority of the cases from the original published articles in journals of
repute. Clinical trials, wherever conducted have been mentioned.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is considered
to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC fingerprint details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first ix volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the quantitative
standards (Appendix I), phytochemical evaluation (Appendix 11), methods for the
isolation of markers (Appendix 11I), methods of drying and storage of raw
material (Appendix IV), limits of pesticide residues and microbial
contamination (Appendix V) and plants allocated to various institutes for
preparing the monographs (Appendix VI). The appendices section is followed by
indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><b >Volume 8<o:p></o:p></b></p>
<p >Edition: 2010</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >Medicinal plants play a significant role both in the
developed and developing countries in providing health benefits to human
beings. Over the last few decades alternative medicine, which is essentially
plant based, has experienced a remarkable and steady increase all over the
world. This has generated a multifaceted interest in the medicinal plants,
which includes the sourcing of raw material (through cultivation or from wild
populations), preparation of formulations, multi marker based phytochemical
evaluation for standardization, molecular target/cell/enzyme based assays,
pharmacological, toxicological and clinical evaluation to establish efficacy
and safety, of single drugs as well as polyherbal formulations and their large
scale manufacture and marketing. In such a scenario proper quality control of
the herbal raw as well as the finished products becomes essential. This
activity has necessitated the requirement of good quality of raw material,
consequently it became important to establish quality parameters for the herbal
raw material.</p>
<p >Indian Council of Medical Research has taken the initiative
to lay down quality standards of important medicinal plants, as per WHO
guidelines. Reputed institutes have been involved to evolve these standards.
Vital data generated at these institutes and compilation of the requisite
information from literature has resulted in the production of this volume,
which is the eighth in the series and deals with 35 medicinal plants.</p>
<p >I deeply appreciate the efforts of the Chairman and the
members of the various committees viz., Scientific Advisory Group, the Task
Force and the Technical Review Committee. The work would not have been possible
but for the important role played by the collaborative Institutions.</p>
<p >Despite certain limitations, that these standards may have,
it is a step towards improving the quality of finished products. Better quality
would inevitably help in raising the acceptance of Indian plant based health
care products. These quality standards will be of great help to all those
engaged in developing various quality products from Indian medicinal plants.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >In India almost 90 per cent of the raw material for herbal
medicinal products is procured by the industry from wild sources, there is
every possibility of vast variation of chemical constituents in the material
collected from different geographical sources. In addition there is a
possibility of deliberate adulteration or substitution in the genuine raw
material. In such a scenario proper quality control of the herbal raw material
as well as finished products becomes essential.</p>
<p ><o:p> </o:p></p>
<p >In an effort to address this problem, the ICMR initiated
work on Quality Standards of Indian Medicinal Plants, involving laboratories of
reputed institutes of the country to generate requisite data as per prescribed
format for preparing monographs.</p>
<p >Each monograph is titled with botanical nomenclature and
incorporates diagnostic macro and microscopic features, phytochemical
constituents, identification by chromatographic fingerprints (TLC/GLC/HPLC),
quantitative determination of the phytochemical marker using marker compound,
information on pharmacological, clinical, toxicological aspects, dose,
adulterants/substitutes etc.</p>
<p >The present 8th volume in the series of already published 7
volumes contains quality standards of 35 plants. The present Monographs are
outcome of the ICMR programme carried out at Agharkar Research Institute, Pune;
B. V. Patel Pharmaceutical Education & Research Development Centre,
Ahmedabad; Captain Srinivasa Murti Drug Research Institute for Ayurveda,
Chennai; Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal;
National Botanical Research Institute, Lucknow; School of Natural Product
Studies, Jadavpur University, Kolkata; University Institute of Pharmaceutical
Sciences, Panjab University, Chandigarh.</p>
<p >It is hoped that the current volume like the previous
volumes will also be of interest to the herbal drug industry, practitioners of
the Indigenous Systems of Medicine, academicians, researchers, health professionals
and regulatory authorities.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw materials involving
several research institutes of country to address this problem. This programme
has resulted in publication of seven volumes on "Quality Standards of
Indian Medicinal Plants" covering 239 plants. The present volume is 8th in
this series and contains monographs on 35 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the parte(s) used, botanical name
with authority, synonyms, habit and distribution of the plant. Other Names:
Include vernacular names of the drug (part of the plant that is being used) in
different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.,
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological, clinical
and other biological activities of the part of the plant described as drug. The
information is derived in majority of the cases from the original published
articles in journals of repute.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is
considered to be safe in the dose traditionally used.</p>
<p ><o:p> </o:p></p>
<p >Dose: Is taken from the Classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first seven volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II),
methods for the isolation of markers (Appendix III), methods of drying and
storage of raw material (Appendix IV), limits of pesticide residues and
microbial contamination (Appendix V) and plants allocated to various institutes
for preparing the monographs (Appendix VI). The appendices section is followed
by indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 9<o:p></o:p></b></p>
<p >Edition: 2011</p>
<p ><b >Foreword</b></p>
<p >One of the stumbling blocks in the popularity and wider
acceptance of herbal drugs is the inadequacy or lack of standards. This is
primarily attributed to the raw material which is not of desired quality, as
required for reliable biological, pharmacological and clinical evaluation
besides their use in health. Therefore, it is imperative to ensure proper
safety and adequate standards along with accurate information available to
those who wish to conduct research and commercialize the product outcome in this
area of life science.</p>
<p >Indian Council of Medical Research has taken the initiative
to lay down quality standards of important medicinal plants, as per WHO
guidelines. Reputed institutes have been involved to evolve these standards.
Vital data generated at these institutes and compilation of the requisite
information from literature has resulted in the production of this volume,
which is ninth in the series and deals with 35 medicinal plants.</p>
<p >I deeply appreciate the efforts of the chairman and the
members of the various committees viz., Scientific Advisory Group, the Task
Force and the Technical Review Committee as also the important role played by
the investigators and the collaborative Research Institutions in bringing out
this publication.</p>
<p ><o:p> </o:p></p>
<p >The plant based drug industry, drug testing laboratories,
academicians, researchers, health professionals and regulatory authorities will
find this book useful. Despite certain limitations, that these standards may
have, it is a step towards improving the quality of finished products.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >In India where 90 per cent of the raw material for herbal
medicinal products is procured by the industry from wild sources, there is
every possibility of vast variation of chemical constituents in the material
collected from different geographical sources. In addition there is a
possibility of deliberate adulteration or substitution of the genuine raw
material. In such a scenario proper quality control of the herbal raw material
and finished products become essential. Thus, the need for development of
quality standards and preparation of monographs thereof cannot be over
emphasized.</p>
<p >In an effort to address this problem, ICMR initiated work on
Quality Standards of Indian Medicinal plant, involving laboratories of reputed
institutes of the country to generate requisite data as per prescribed format
for preparing monographs.</p>
<p >Each monograph is titled with botanical nomenclature and
incorporates diagnostic macro and microscopic features, phytochemical
constituents, identification by chromatographic fingerprints (TLC/GLCIHPLC),
quantitative determination of the phytochemical marker using marker compound
and information on pharmacological, clinical, toxicological as well as parts
used, dose, adulterants/ substitutes etc.</p>
<p >The present 9th volume in the series of already published 8
volumes contains quality standards of 35 plants. The monographs are outcome of
the ICMR programme carried out at B.V. Patel Pharmaceutical Education and
Research Development Centre, Ahmedabad, Gujarat; Captain Sriniva a Murti Drug
Research Institute for Ayurveda, Chennai, Tamil Nadu; Centre for Medicinal
Plants Research, Arya Vaidya Sala, Kottakkal, Kerala and L. M. College of
Pharmacy, Ahmedabad, Gujarat.</p>
<p >Better quality would inevitably help in raising the
acceptance of Indian plant based health care products. It is hoped that the
current volume like the previous volumes will be of interest to those engaged
in developing various quality products from Indian Medicinal Plants.</p>
<p >Preparation of the tenth volume in the series is in
progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw materials involving
several research institutes of country to address this problem. This programme
has resulted in publication of eight volumes on "Quality Standards of
Indian Medicinal Plants" covering 274 plants. The present volume is 9th in
this series and contains monographs on 35 plants.</p>
<p ><o:p> </o:p></p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution ofthe plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic details,
the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.,
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p ><o:p> </o:p></p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological, clinical
and other biological activities of the part of the plant described as drug. The
information is derived in majority of the cases from the original published
articles in journals of repute.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is
considered to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the Classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first eight volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II),
methods for the isolation of markers (Appendix III), methods of drying and
storage of raw material (Appendix IV), limits of pesticide residues and
microbial contamination (Appendix V) and plants allocated to various institutes
for preparing the monographs (Appendix VI). The appendices section is followed
by indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 10<o:p></o:p></b></p>
<p >Edition: 2012</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >The global interest in Medicinal Plants and the fast
expanding world market during the last two decades have necessitated quality
ensured herbal drugs. An increase in the incidence of toxicity reported due to
indiscriminate use, deliberate or undeliberate adulteration/substitution and presence
of contaminants in herbal preparations available over the counter and as food
supplements make it important to ensure their quality, safety and efficacy.
Quality standards of the Indian Medicinal Plants are necessary for the drugs
and formulations produced from them to be of adequate quality, safety and
efficacy for their wider acceptance and patients interest.</p>
<p >In response to this need, the Indian Council of Medical
Research took initiative in the year 2001 to lay down quality standards of
important Medicinal Plants as per WHO guidelines. The endeavour yielded very
fruitful results evidenced by the publication of 9 volumes of Quality Standards
of Indian Medicinal Plants containing 309 monographs. Under this continuing
programme, this tenth volume on Quality Standards of another 35 Indian
Medicinal Plants is being published.</p>
<p >Despite certain limitations that these standards may have,
it is a step towards improving the quality of finished products. Better quality
would inevitably help in raising the acceptance of Indian plant based health
care products. These quality standards will be of great help to all those
engaged in developing various quality products from Indian Medicinal Plants.</p>
<p >I deeply appreciate the efforts of the chairman and the
members of the various committees, viz., Scientific Advisory Group, the Task
Force and the Technical Review Committee as also the important role played by
the investigators and the collaborative Research Institutions who have
contributed to the significant task of developing quality standards.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >Medicinal plants remain the main source of medicines for a
large proportion of global population particularly in the developing world. In
India the raw material for herbal medicinal products is mostly procured from
wild sources, there is every possibility of vast variation of chemical
constituents in the material collected from different geographical sources.
There is also a possibility of deliberate adulteration and substitution in the
genuine raw material. In such a scenario the proper quality control of the
herbal raw material as well as the finished products become essential.
Moreover, the quality of raw materials used in the herbal drugs assumes special
significance particularly in context of conducting experimental studies,
clinical trials and their therapeutic value.</p>
<p >The Medicinal Plants Unit of the Indian Council of Medical
Research took initiatives for developing Quality Standards of Medicinal Plants
for more widely used raw materials involving laboratories of reputed institutes
in the country to generate requisite data as per prescribed format for
preparing monographs. Each monograph is titled with botanical nomenclature and
incorporates diagnostic macro- and microscopic features, phytochemical
constitutents, identification by chromatographic fingerprints (TLCIGLCIHPLC),
quantitative determination of the phytochemical marker using reference marker
compound, information on pharmacological, clinical, toxicological aspects,
dose, adulterants / substitutes etc.</p>
<p >The present 10th volume in the series contains quality
standards of 35 medicinal plants. The monographs are outcome of the ICMR
programme carried out at Agharkar Research Institute, Pune, Maharashtra;
Captain Srinivasa Murti Drug Research Institute for Ayurveda, Chennai, Tamil
Nadu; Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, Kerala
and L. M. College of Pharmacy, Ahmedabad, Gujarat.</p>
<p ><o:p> </o:p></p>
<p >As with the earlier nine volumes published, the tenth volume
in the series is also expected to be well received and useful to the herbal
drug industry, practitioners of Indigenous system of Medicine, academicians,
researchers and health professionals including regulatory authorities.</p>
<p >Preparation of the Eleventh volume in the series is in
progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants U nit of the Indian Council of Medical Research has initiated a
programme for the preparation of quality standards for herbal raw materials
involving several research institutes of country to address this problem. This
programme has resulted in publication of nine volumes on "Quality
Standards of Indian Medicinal Plants" covering 309 plants. The present
volume is l O" in this series and contain monographs on 35 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compound and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, vir.,
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the case, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO
guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological, clinical
and other biological activities of the part of the plant described as drug. The
information is derived in majority of the cases from the original published
articles in journals of repute.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is
considered to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the Classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print detail and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first nine volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II), methods
for the isolation of markers (Appendix ill), methods of drying and storage of
raw material (Appendix IV), limits of pesticide residues and microbial
contamination (Appendix V) and plants allocated to various institutes for
preparing the monographs (Appendix VI). The appendices section is followed by
indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><b >Volume 11<o:p></o:p></b></p>
<p >Edition: 2013</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >Medicinal plants play a significant role both in developed
and developing countries in providing health benefits to human beings. Over the
last few decades use of complimentary alternative medicines which are
essentially plant based, have experienced a remarkable and steady increase in
the world. This has generated a multifaceted interest in the medicinal plants
including the sourcing of raw material, preparation of formulations,
multimarker based phytochemical evaluation for standardization, molecular
target based assays, pharmacological, toxicological and clinical evaluation to establish
safety and efficacy of single plant drugs as well as polyherbal formulations
and their large scale manufacture and marketing. In such a scenario proper
quality controls of the herbal raw material as well as the finished products
become essential. This activity has necessitated the requirement of good
quality of raw material, consequently it became important to establish quality
parameters of the raw material.</p>
<p >In response to this need, the Indian Council of Medical
Research took initiative in the year 2001 to lay down quality standards of
important Medicinal plants as per WHO guidelines. The endeavour yielded very
fruitful results evidenced by the publication of 10 volumes of Quality
Standards of Indian Medicinal Plants containing 344 monographs. Under this
continuing programme, this eleventh volume of Quality Standards of another 35
Indian Medicinal Plants is being published. This endevour may help in improving
quality of plant based drugs in our country.</p>
<p >I deeply appreciate the efforts of the chairman and the
members of the various committees, viz., Scientific Advisory Group, the Task
Force and the Technical Review Committee as also the important role played by
the investigators and the Collaborative Research Institutions who have
contributed to the significant task of developing quality standard monographs.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >In India about 90 percent of raw material for herbal
medicinal products is procured by the industry from wild sources, there is
every possibility of vast variation of chemical constituents in the material
collected from different geographical sources. In addition there is a
possibility of deliberate adulteration or substitution in the genuine raw
material. In such a scenario, proper quality control of the herbal raw material
becomes essential.</p>
<p ><o:p> </o:p></p>
<p >In an effort to address this problem, the ICMR initiated
work an Quality Standards of Indian Medicinal Plants, involving laboratories of
reputed institutes of the country to generate requisite data as per prescribed
format for preparing monographs.</p>
<p >Each monograph is titled with botanical nomenclature and
incorporates diagnostic macro- and microscopic features, phytochemical
constituents, identification by chromatographic fingerprints
(TLC/GLCIHPLCIHPTLC), quantitative determination of the phytochemical marker
using reference phytochemical standards, information on pharmacological,
clinical, toxicological aspects, dose, adulterants/substitutes etc.</p>
<p >The present 11th volume in the series of the already
published 10 volumes contains quality standards of35 medicinal plants. The
present publication is an outcome of the ICMR programme under which work was
carried out at Agharkar Research Institute, Pune, Maharashtra; Captain
Srinivasa Murti Drug Research Institute for Ayurveda and Siddha, Chennai, Tamil
Nadu; Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal,
Kerala; Institute of Chemical Technology, Mumbai, Maharashtra; Jamia Hamdard,
New Delhi and L. M. College of Pharmacy, Ahmedabad, Gujarat.</p>
<p >It is hoped that the current volume like the previous ones
will also be of interest to the herbal drug industry, pharmaceutical and
Ayurvedic academic/research institutes, practitioners of the Indigenous Systems
of medicine and health professionals including regulatory authorities.</p>
<p >Preparation of the twelfth volume in the series is in
progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw materials involving
several research institutes of the country to address this problem. This
programme has resulted in publication often volumes on "Quality Standards
of Indian Medicinal Plants" covering 344 plants. The present volume is
11th in this series and contains monographs on 35 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p ><o:p> </o:p></p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.,
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p ><o:p> </o:p></p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values are derived by employing standard methodology and techniques as
given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of India or WHO guidelines
for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological, clinical
and other biological activities of the part of the plant described as drug. The
information is derived in majority of the cases from the original published
articles in journals of repute.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is
considered to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the Classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first ten volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the quantitative
standards (Appendix I), phytochemical evaluation (Appendix II), methods for the
isolation of markers (Appendix III), methods of drying and storage of raw
material (Appendix IV), limits of pesticide residues and microbial
contamination (Appendix V) and plants allocated to various institutes for
preparing the monographs (Appendix VI). The appendices section is followed by
indices on the botanical names, chemical constituents and names of plants in
other languages.</p>
<p ><o:p> </o:p></p>
<p ><span > </span></p>
<p ><b >Volume 12<o:p></o:p></b></p>
<p >Edition: 2014</p>
<p ><b >Foreword<o:p></o:p></b></p>
<p >Medicinal plants play a significant role both in developed
and developing countries in providing health benefits to human beings. Over the
last few decades plant based medicines have been steadily gaining importance in
the world. This has generated a multifaceted interest in the medicinal plants,
including sourcing of raw material, preparation of formulations, multimarker
based phytochemical evaluation for standardization, molecular target based
assays, pharmacological, toxicological and clinical evaluation to establish
safety and efficacy of single drugs as well as polyherbal formulations and
their large scale manufacture and marketing. In such a scenario proper quality
control of the herbal raw as well as the finished products becomes essential.
This activity has necessitated the requirement of good quality of raw material,
consequently it became important to establish quality parameters of the raw
materials.</p>
<p >In response to this growing need, Indian Council of Medical
Research took initiative in the year 200 1 to lay down quality standards of
important Medicinal plants as per WHO guidelines. The endeavour yielded very
fruitful results evidenced by the publication of 11 volumes of Quality
Standards of Indian Medicinal Plants containing 379 monographs. Under this
continuing programme, this twelfth volume of Quality Standards of another 35
Indian Medicinal Plants is being published.</p>
<p >Despite certain limitations that these standards may have,
it is a step towards improving the quality of finished products.</p>
<p >I deeply appreciate the efforts of the chairman and the
members of the various committees, viz., Scientific Advisory Group, the Task
Force and the Technical Review Committee as well as investigators and the
various Research Institutions who have contributed to the significant task of
developing quality standard monographs.</p>
<p ><b >Preface<o:p></o:p></b></p>
<p >In India about 90 per cent of raw material for herbal
medicinal products is procured by the industry from wild sources, there is
every possibility of vast variation of chemical constituents in the material
collected from different geographical sources. In addition there is a
possibility of deliberate adulteration or substitution in the genuine raw
material. In such a scenario proper quality control of the herbal raw material
as well as finished products becomes essential.</p>
<p >In an effort to address this problem, ICMR initiated work on
Quality Standards of Indian Medicinal Plants, involving laboratories of reputed
institutes of the country to generate requisite data as per prescribed format
for preparing monographs.</p>
<p >Each monograph is titled with botanical nomenclature and
incorporates diagnostic macro and microscopic features, phytochemical
constituents, identification by chromatographic fingerprints
(TLCIGLC/HPLC/HPTLC), quantitative determination of the phytochemical marker
using marker compound, information on pharmacological, clinical, toxicological
aspects, dose, adulterants/ substitutes etc.</p>
<p >The present 12th volume in the series of the already
published 11 volumes contains quality standards of 35 plants. The present
publication is an outcome of the ICMR programme under which work was carried
out at Agharkar Research Institute, Pune, Maharashtra; Centre for Medicinal
Plants Research, Arya Vaidya Sala, Kottakkal, Kerala; Institute of Chemical
Technology, Mumbai, Maharashtra and Jamia Hamdard, New Delhi.</p>
<p >It is hoped that the current volume like the previous
volumes will also be of interest to the herbal drug industry, pharmaceutical
and Ayurvedic academic/research institutes, practitioners of the Indigenous
systems of medicine and health professionals including regulatory authorities.</p>
<p >Preparation of the thirteenth volume in the series is in
progress.</p>
<p ><b >Introduction<o:p></o:p></b></p>
<p >Lack of quality standards of the raw material has been one
of the major lacuna in the wider acceptance of plant based drugs. Medicinal
Plants Unit of the Indian Council of Medical Research has initiated a programme
for the preparation of quality standards for herbal raw materials involving
several research institutes of the country to address this problem. This
programme has resulted in publication of eleven volumes on "Quality
Standards of Indian Medicinal Plants" covering 379 plants. The present
volume is 12th in this series and contains monographs on 35 plants.</p>
<p >The following major guidelines have been adopted in evolving
the standards and preparation of the monographs.</p>
<p >The raw material of the plants is procured from the field,
from at least three geographical locations and authenticated. The samples are
worked out for their pharmacognostic and phytochemical features through
experiments while the information on the distribution of the plants, vernacular
names, chemical constituents, pharmacological activity, safety aspects,
clinical studies if any, therapeutic claims and any other details are derived
from the published literature and compiled in the form of a monograph, along
with complete references of the work cited. The experiments conducted and the
compiled data is subjected to careful scrutiny by the experts of the scientific
committee. The information incorporated in the monographs is further supported
by the photographs of the plant, the part/s of the plant used, microscopic
details, the TLC details, chromatograms, etc.</p>
<p >The monographs are compiled and presented in a uniform
format as described below:</p>
<p >Each monograph starts with the part(s) used, botanical name
with authority, synonyms, habit and distribution of the plant.</p>
<p >Other Names: Include vernacular names of the drug (part of
the plant that is being used) in different regions of the country.</p>
<p >Description: Contains macroscopy and microscopy of the drug
with special emphasis on diagnostic characteristics, organoleptic examination
of the raw material as well as its powder. Illustrated figures and photographs
are also given.</p>
<p >Chemical Constituents: Are given with the structures of
important compounds and active principles (if known). While making the
structures of the chemical constituents, stereochemistry is also taken into
consideration wherever information on stereochemistry of specific compounds is
available. The chemical constituents are listed under two sub heads, viz.,
major and others. Under the former category, the chemical constituents which
are either present in significant amount in the drug or are important from the
activity point of view (active principle of the drug), even if present in
relatively small amounts. Under the second category, the chemical constituents
which are either present in small amount or their contribution towards the
activity of the drug is not known, are listed.</p>
<p >Identity Tests: Chromatographic fingerprint profiles which
have been generated using thin layer chromatography, high performance liquid
chromatography or gas liquid chromatography, as per the suitability are given.
TLC is found to be more practically feasible and suitable to resolve most of
the components of the extract under study. As far as possible, fingerprint
profiles are given along with a marker compound.</p>
<p ><o:p> </o:p></p>
<p >Assay/Analytical Methods: Are described in detail for the
analysis of marker compound. In certain cases, chemical groups are estimated.
In all the cases, sample preparation is optimized to enable complete extraction
of compounds of interest.</p>
<p >Quantitative Standards: With respect to extractive values
and ash values, these are derived by employing standard methodology and
techniques as given in the Indian Pharmacopoeia or Ayurvedic Pharmacopoeia of
India or WHO guidelines for Quality Standards of Medicinal Plants.</p>
<p >Adulterants/Substitutes: Are given wherever information is
available and distinguishing features are cited with appropriate references.</p>
<p >Pharmacology: Includes important pharmacological, clinical
and other biological activities of the part of the plant described as drug. The
information is derived in majority of the cases from the original published
articles in journals of repute.</p>
<p >Major Therapeutic Claims: Are derived from classical texts
of Ayurveda with appropriate references and also other standard publications or
evidenced by clinical trials reported in the literature.</p>
<p >Safety Aspects: Incorporates data available on the drug
along with appropriate references. If no specific toxicity is reported, it is
considered to be safe in the dose traditionally used.</p>
<p >Dose: Is taken from the Classical Ayurvedic texts or from
literature, if published.</p>
<p >The monograph is supported by colour photographs of the
plant, the part of the plant used as drug, photomicrographs and/or camera
lucida diagrams of the sections of the drug, and TLC finger print details and
chromatograms, supported with complete references of the work cited.</p>
<p >In the initial pages of the book abbreviations used are
listed, and the plants included in the first eleven volumes are also listed for
ready reference. Towards the end of the volume, relevant appendices are
included, carrying details of the methods for pharmacognostic evaluation of the
raw material which includes macroscopic, microscopic studies and the
quantitative standards (Appendix I), phytochemical evaluation (Appendix II),
methods for the isolation of markers (Appendix III), methods of drying and storage
of raw material (Appendix IV), limits of pesticide residues and microbial
contamination (Appendix V) and plants allocated to various institutes for
preparing the monographs (Appendix VI). The appendices section is followed by
indices on the botanical names, chemical constituents, names of plants in other
languages and a list of monographs published in the earlier volumes (Vols
1-11).</p>
<p ><b >Content Volume 1<o:p></o:p></b></p>
<p ><span > </span></p>
<p ><o:p> </o:p></p>
<p ><span > </span><span
> </span>Message<span style='mso-tab-count:
1'> </span>v</p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>vii</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>ix</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>xi</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>xii</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>xv</p>
<p ><span > </span><span
> </span>Monographs<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Abutilon
indicum (Linn.) Sweet<span > </span>1</p>
<p >2<span > </span>Alpinia
galanga (Linn.) Willd.<span > </span>7</p>
<p >3<span > </span>Arnebia
euchroma (Royle) Johnston var. euchroma<span > </span>13</p>
<p >4<span > </span>Artemisia
annua Linn.<span > </span>21</p>
<p >5<span > </span>Asparagus
racemosus Willd.<span > </span>27</p>
<p >6<span > </span>Bergenia
ciliata (Haw.) Sternb. forma ligulata Yeo<span > </span>34</p>
<p >7<span > </span>Butea
monosperma (Lamk.) Taub.<span > </span>40</p>
<p >8<span > </span>Cassia
occidentalis Linn.<span > </span>47</p>
<p >9<span > </span>Cassia
senna Linn. var. senna<span > </span>57</p>
<p >10<span > </span>Cinchona
officinalis Linn.f.<span > </span>65</p>
<p >11<span > </span>Cinnamomum
verum J.S. Presl<span > </span>74</p>
<p >12<span > </span>Curcuma
amada Roxb.<span > </span>82</p>
<p >13<span > </span>Cyperus
rotundus Linn.<span > </span>89</p>
<p >14<span > </span>Elettaria
cardamomum (Linn.) Maton<span > </span>95</p>
<p >15<span > </span>Gymnema
sylvestre (Retz.) Schult.<span > </span>102</p>
<p >16<span > </span>Holarrhena
antidysenterica (Roth) DC.<span > </span>109</p>
<p >17<span > </span>Jatropha
glandulifera Roxb.<span > </span>117</p>
<p >18<span > </span>Lawsonia
inermis Linn.<span > </span>123</p>
<p >19<span > </span>Moringa
oleifera Lamk.<span > </span>130</p>
<p >20<span > </span>Mucuna
pruriens (Linn.) DC.<span > </span>136</p>
<p >21<span > </span>Murraya
koenigii (Linn.) Spreng.<span > </span>142</p>
<p >22<span > </span>Myristica
fragrans Houtt.<span > </span>150</p>
<p >23<span > </span>Nigella
sativa Linn.<span > </span>161</p>
<p >24<span > </span>Piper longum
Linn.<span > </span>168</p>
<p >25<span > </span>Pueraria
tuberosa (Roxb. ex Willd.) DC.<span > </span>174</p>
<p >26<span > </span>Sida acuta
Burm. f. ssp. acuta<span > </span>181</p>
<p >27<span > </span>Tephrosia
purpurea (Linn.) Pers.<span > </span>187</p>
<p >28<span > </span>Terminalia
bellirica (Gaertn.) Roxb.<span > </span>198</p>
<p >29<span > </span>Terminalia
chebula (Gaertn.) Retz.<span > </span>205</p>
<p >30<span > </span>Tinospora
cordifolia (Will. ) Miers ex Hook.f. & Thoms.<span style='mso-tab-count:
1'> </span>212</p>
<p >31<span > </span>Tylophora
indica (Burm.f.) Merrill<span > </span>219</p>
<p >32<span > </span>Wedelia
chinensis (Osbeck) Merrill<span > </span>226</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>235</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>238</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>242</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>243</p>
<p >V<span > </span>Pesticides,
residues and microbial contamination<span > </span>244</p>
<p >VI<span > </span>Plants
allocated to various Institutes<span > </span>246</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>247</p>
<p >II<span > </span>Chemical
constituents<span > </span>249</p>
<p >III<span > </span>Other
names of the plants<span > </span>255</p>
<p ><span > </span></p>
<p ><o:p> </o:p></p>
<p ><b >Content Volume 2<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>v</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>vii</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>viii</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>ix</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>xi</p>
<p ><span > </span><span
> </span>Quality Standards of Indian
Medicinal Plants Covered in Volume-1<span > </span>xiii</p>
<p ><span > </span><span
> </span>Monographs<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Albizia
lebbeck (Linn.) Benth<span > </span>1</p>
<p >2<span > </span>Aristolochia
indica Linn<span > </span>9</p>
<p >3<span > </span>Boswellia
serrata Roxb. Ex Cloebr<span > </span>19</p>
<p >4<span > </span>Caesalpinia
bonduc (Linn.) Roxb. emend. Dandy & Exell<span > </span>25</p>
<p >5<span > </span>Calotropis
giganted (Linn.) R. Br.<span > </span>34</p>
<p >6<span > </span>Cassia
fistula Linn.<span > </span>47</p>
<p >7<span > </span>Catharanthus
roseus (Linn.) G. Don<span > </span>54</p>
<p >8<span > </span>Cissus
quadrangularis Linn<span > </span>62</p>
<p >9<span > </span>Convolvulus
microphyllus Sieb. ex Spreng<span > </span>70</p>
<p >10<span > </span>Coscinium
fenestratum (Gaertn.) Colebr.<span > </span>79</p>
<p >11<span > </span>Dactylorhiza
hatagirea (D. Don) soo<span > </span>87</p>
<p >12<span > </span>Digitalis
lanata Ehrh<span > </span>94</p>
<p >13<span > </span>Euphorbia
prostrata W. Ait<span > </span>103</p>
<p >14<span > </span>Euphorbia
tirucalli Linn<span > </span>112</p>
<p >15<span > </span>Hemidesums
indicus (Linn.) R. Br.<span > </span>119</p>
<p >16<span > </span>Hibiscus
rosa- sinensis Linn<span > </span>129</p>
<p >17<span > </span>Hypericum
perforatum Linn<span > </span>136</p>
<p >18<span > </span>Leucas
cephalotes (Roth) Spreng<span > </span>146</p>
<p >19<span > </span>Malaxis
acuminata D. Don<span > </span>155</p>
<p >20<span > </span>Mimusops
elengi Linn<span > </span>161</p>
<p >21<span > </span>Ocimum
basilicum Linn<span > </span>168</p>
<p >22<span > </span>Ocimum
gratisslimum Linn<span > </span>176</p>
<p >23<span > </span>Phyllanthus
maderaspatensis Linn.<span > </span>184</p>
<p >24<span > </span>Rauvolfia
tetraphylla Linn.<span > </span>193</p>
<p >25<span > </span>Saraca asoca
(Roxb.) de Wilde<span > </span>201</p>
<p >26<span > </span>Sida
rhombifolia Linn. ssp. rhombifolia<span > </span>209</p>
<p >27<span > </span>Silybum
marianum (Linn.) Gaertn.<span > </span>217</p>
<p >28<span > </span>Streblus
asper Lour.<span > </span>227</p>
<p >29<span > </span>Taxus
wallichiana Zucco<span > </span>235</p>
<p >30<span > </span>.Terminalia
arjuna (Roxb.) wight & Arn<span > </span>243</p>
<p >31<span > </span>Thevetia
peruviana (Pers.) K.Schum.<span > </span>253</p>
<p >32<span > </span>Trianthema
portulacastrum Linn.<span > </span>261</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>273</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>276</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>280</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>282</p>
<p >V<span > </span>Pesticide
residues and microbial contamination<span > </span>283</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>285</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>286</p>
<p >II<span > </span>Chemical
constituents<span > </span>288</p>
<p >III<span > </span>Other
names of the plants<span > </span>296</p>
<p ><span > </span></p>
<p ><b >Content Volume 3<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>v</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>vii</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>viii</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>ix</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>xiii</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>xv</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>xvi</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Adhatoda
beddomei Clarke<span > </span>1</p>
<p >2.<span > </span>Aerva
lanata (Linn.) Juss.<span > </span>9</p>
<p >3.<span > </span>Ailanthus
excelsa Roxb.<span > </span>20</p>
<p >4.<span > </span>Allium
cepa Linn.<span > </span>29</p>
<p >5.<span > </span>Allium
sativum Linn.<span > </span>38</p>
<p >6.<span > </span>Alstonia
scholaris (Linn.) R.Br.<span > </span>48</p>
<p >7. .<span > </span>Anogeissus
latifolia (Roxb. ex DC.) Wall. ex Guill. & Perr<span style='mso-tab-count:
1'> </span>61</p>
<p >8.<span > </span>Areca catechu
Linn.<span > </span>69</p>
<p >9.<span > </span>Berberis
aristata DC. var. aristata<span > </span>78</p>
<p >10.<span > </span>Calophyllum
inophyllum Linn.<span > </span>88</p>
<p >11.<span > </span>Capparis
decidua (Forsk.) Edgew.<span > </span>98</p>
<p >12.<span > </span>Carissa
carandas Linn.<span > </span>107</p>
<p >13.<span > </span>Catunaregam
spinosa (Thunb.) Tiruv. ssp. spinosa<span > </span>115</p>
<p >14.<span > </span>Cichorium
intybus Linn ..<span > </span>126</p>
<p >15.<span > </span>Cinnamomum
camphora (Linn.) Presl<span > </span>135</p>
<p >16.<span > </span>Cinnamomum
tamala (Buch.-Ham.) Nees & Eberm.<span > </span>149</p>
<p >17.<span > </span>Cissampelos
pareira Linn. var. hirsuta (Buch.-Ham. ex DC.) Forman<span style='mso-tab-count:
1'> </span>158</p>
<p >18.<span > </span>Clerodendrum
serratum (Linn.) Moon<span > </span>167</p>
<p >19.<span > </span>Commiphora
wightii (Arnott) Bhandari<span > </span>177</p>
<p >20.<span > </span>Dendrophthoe
falcata (Linn.f.) Etting.<span > </span>189</p>
<p >21.<span > </span>Dioscorea
deltoidea Wall. ex Kunth<span > </span>195</p>
<p >22<span > </span>Enicostemma
hysspifolium (Willd.) Verd<span > </span>203</p>
<p >23<span > </span>Euphorbia
thymifolia Linn<span > </span>212</p>
<p >24<span > </span>Ficus virens
Ait<span > </span>222</p>
<p >25<span > </span>Garcinia
gummi-gutta (Linn.)Rob<span > </span>229</p>
<p >26<span > </span>Leptadenia
retuculata (Retz.) Wight & Arn<span > </span>236</p>
<p >27<span > </span>Merremia
turpethum (Linn.) shaw & Bhatt<span > </span>246</p>
<p >28<span > </span>Mesua ferrea
Linn. Var. ferrea<span > </span>254</p>
<p >29<span > </span>Momordica
charantia Linn<span > </span>262</p>
<p >30<span > </span>Nelumbo
charantia Linn<span > </span>271</p>
<p >31<span > </span>Nyctanthes
arbor-tristis Linn<span > </span>281</p>
<p >32<span > </span>Psoralea
corylifolia Linn<span > </span>290</p>
<p >33<span > </span>Punica granatum
Linn<span > </span>299</p>
<p >34<span > </span>Rubia
cordifolia Linn<span > </span>307</p>
<p >35<span > </span>Sapindus
laurifolius Vahl<span > </span>316</p>
<p >36<span > </span>Sapindus
mukorossi Gaertn<span > </span>328</p>
<p >37<span > </span>Tecomella
undulata (Sm.) Seem<span > </span>340</p>
<p >38<span > </span>Trachyspermum
ammi (Linn.) Sprague<span > </span>349</p>
<p >39<span > </span>Vitex
negundo Linn<span > </span>357</p>
<p >40<span > </span>Woodfordia
fruticosa (Linn.) Kurz<span > </span>367</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evalution
of crude drugs<span > </span>377</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>380</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>384</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>387</p>
<p >VI<span > </span>Pesticide
residues and microbial contamination<span > </span>388</p>
<p >VII<span > </span>Plants
allocated to various institute<span > </span>390</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>392</p>
<p >II<span > </span>Chemical
constituents<span > </span>394</p>
<p >III<span > </span>Other
names of the plants<span > </span>404</p>
<p ><span > </span><b style='mso-bidi-font-weight:
normal'>Content Volume 4<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>v</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>vii</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>viii</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>ix</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>xiii</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>xv</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>xvi</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>xvii</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Aconitum
heterophyllum Wall. ex Royle<span > </span>1</p>
<p >2<span > </span>Aesculus
indica Colebr. ex Camb.<span > </span>9</p>
<p >3<span > </span>Anethum
sowa Roxb. ex Flem.<span > </span>18</p>
<p >4<span > </span>Asparagus adscendens
Roxb.<span > </span>28</p>
<p >5<span > </span>Barleria
prionitis Linn.<span > </span>36</p>
<p >6<span > </span>Cannabis
sativa Linn.<span > </span>46</p>
<p >7<span > </span>Carum
carvi Linn.<span > </span>57</p>
<p >8<span > </span>Chlorophytum
arundinaceum Baker<span > </span>67</p>
<p >9<span > </span>Citrullus
colocynthis (Linn.) Schrard.<span > </span>76</p>
<p >10<span > </span>Clitoria
ternatea Linn.<span > </span>84</p>
<p >11<span > </span>Coix
lachryma-jobi Linn.<span > </span>92</p>
<p >12<span > </span>Colchicum luteum
Baker<span > </span>99</p>
<p >13<span > </span>Coleus
forskohlii (Willd.) Briq.<span > </span>107</p>
<p >14<span > </span>Cynodon
dactylon (Linn.) Pers.<span > </span>116</p>
<p >15<span > </span>Drimia
indica (Roxb.) Jessop.<span > </span>123</p>
<p >16<span > </span>Embelia
ribes Burm.f.<span > </span>130</p>
<p >17<span > </span>Ephedra
gerardiana Wall. ex Stapf<span > </span>137</p>
<p >18<span > </span>Evolvulus
alsinoides (Linn.) Linn.<span > </span>145</p>
<p >19<span > </span>Hygrophila auriculata
(K. Schum.) Heine<span > </span>154</p>
<p >20<span > </span>Hyoscyamus
niger Linn<span > </span>161</p>
<p >21<span > </span>Inula
racemosa Hook.f.<span > </span> </p>
<p >21<span > </span>Inula
racamosa Hook. F.<span > </span>169</p>
<p >22<span > </span>Pedalium
murex Linn<span > </span>178</p>
<p >23<span > </span>Pluchea
lanceolata (DC.) Clarke<span > </span>185</p>
<p >24<span > </span>Podophyllum
hexandrum Royle ex Camb<span > </span>194</p>
<p >25<span > </span>Saussurea
costus (Falc) Lipsch<span > </span>204</p>
<p >26<span > </span>Symplocos
racemosa Roxb<span > </span>215</p>
<p >27<span > </span>Trichosanthes
tricuspidata Lour<span > </span>224</p>
<p >28<span > </span>Trigonella
foenum-graecum Linn<span > </span>232</p>
<p >29<span > </span>Valeriana
jatamansi Jones<span > </span>242</p>
<p >30<span > </span>Vetiveria
zizanioides (Linn.) Nash<span > </span>251</p>
<p >31<span > </span>Writhtia
tinctoria R. Br.<span > </span>262</p>
<p >32<span > </span>Zanthoxylum
armatum DC.<span > </span>271</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>281</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>284</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>288</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>292</p>
<p >V<span > </span>Pesticide
residues and microbial contamination<span > </span>293</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>295</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>296</p>
<p >II<span > </span>Chemical
constituents<span > </span>298</p>
<p >III<span > </span>Other
names of the plants<span > </span>310</p>
<p ><span > </span></p>
<p ><b >Content Volume 5<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span> </p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>v</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>vii</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>viii</p>
<p ><span > </span><span
> </span>Introduction ,,~<span
> </span>ix</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>xiii</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>xv</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>xvi</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>xvii</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span>xix</p>
<p >1<span > </span>Abelmoschus
moschatus (Linn.) Medik.<span > </span> </p>
<p >2<span > </span>Acacia
nilotica (Linn.) Willd. ex Delile ssp. indica (Benth.) Brenan<span
> </span>1</p>
<p >3<span > </span>Achillea
millefolium Linn.<span > </span>8</p>
<p >4<span > </span>Agave
americana Linn.<span > </span>13</p>
<p >5<span > </span>Alangium
salvifolium (Linn.f.) Wang. var. salvifolium<span > </span>24</p>
<p >6<span > </span>Altemanthera
sessilis (Linn.) R. Br. ex DC.<span > </span>35</p>
<p >7<span > </span>Ammi majus
Linn.<span > </span>43</p>
<p >8<span > </span>Anthocephalus
chinensis (Lamk.) A. Rich. ex Walp.<span > </span>54</p>
<p >9<span > </span>Argyreia
nervosa (Burm.f.) Bojer<span > </span>63</p>
<p >10<span > </span>Aristolochia
bracteolata Lamk.<span > </span>75</p>
<p >11<span > </span>Avicennia
officinalis Linn.<span > </span>84</p>
<p >12<span > </span>Balanites
aegyptiaca (Linn.) Delile<span > </span>91</p>
<p >13<span > </span>Basella alba
Linn. var. alba<span > </span>98</p>
<p >14<span > </span>Bauhinia
variegata Linn.<span > </span>116</p>
<p >15<span > </span>Bombax ceiba
Linn.<span > </span>125</p>
<p >16<span > </span>Callicarpa
macrophylla Vahl<span > </span>134</p>
<p >17<span > </span>Calotropis
procera (Ait.) Ait. f. ssp. hamiltonii (Wight) Ali<span style='mso-tab-count:
1'> </span>142</p>
<p >18<span > </span>Coccinia
grandis (Linn.) Voigt.<span > </span>157</p>
<p >19<span > </span>Colebrookea
oppositifolia Smith<span > </span>168</p>
<p >20<span > </span>Cryptolepis
buchanani Roem. &: Schult.<span > </span>176</p>
<p >21<span > </span>Cuscuta
reflexa Roxb.<span > </span>184</p>
<p >22<span > </span>Derris
indica (Lamk.) Bennet<span > </span>193</p>
<p >23<span > </span>Didymocarpus
pedicellatus R. Br.<span > </span>209</p>
<p >24<span > </span>Erythrina
variegata Linn.<span > </span>221</p>
<p >25<span > </span>Ferula
assa-foetida Linn.<span > </span>232</p>
<p >26<span > </span>Haldina
cordifolia (Willd. ex Roxb.) Ridsdale<span > </span>238</p>
<p >27<span > </span>Holoptelea
integrifolia (Roxb.) P1anch.<span > </span>246</p>
<p >28<span > </span>Hydnocarpus
pentandra (Buch.-Ham.) Oken<span > </span>256</p>
<p >29<span > </span>Leucas
plukenetii (Roth) Spreng .<span > </span>265</p>
<p >30<span > </span>Ocimum
sanctum Linn.<span > </span>275</p>
<p >3l.<span > </span>Oxalis
corniculata Linn.<span > </span>285</p>
<p >32<span > </span>Peristrophe
paniculata (Forssk.) Brummitt<span > </span>295</p>
<p >33<span > </span>Pimpinella
anisum Linn.<span > </span>304</p>
<p >34<span > </span>Salacia
chinensis Linn.<span > </span>313</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evalutaion
of crude drugs<span > </span>323</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>326</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>330</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>334</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>335</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>337</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>338</p>
<p >II<span > </span>Chemical
constituents<span > </span>340</p>
<p >III<span > </span>Other
names of the plants<span > </span>350</p>
<p ><span > </span></p>
<p ><o:p> </o:p></p>
<p ><b >Contents Volume 6<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Contents of Volume I (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Contents of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Monographs<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Acacia
sinuata (Lour.) Merr.<span > </span>1</p>
<p >2<span > </span>Acanthus ilicifolius
Linn.<span > </span>11</p>
<p >3<span > </span>Ailanthus
triphysa (Dennst.) Alston<span > </span>19</p>
<p >4<span > </span>Anisomeles
malabarica (Linn.) R. Br. ex Sims<span > </span>28</p>
<p >5<span > </span>Aphanamixis
polystachya (Wall.) Parker<span > </span>37</p>
<p >6<span > </span>Bixa
orellana Linn.<span > </span>46</p>
<p >7<span > </span>Blumea
lacera (Burm.f.) DC.<span > </span>55</p>
<p >8<span > </span>Cardiospermum
halicacabum Linn.<span > </span>64</p>
<p >9<span > </span>Cassia
tora Linn.<span > </span>76</p>
<p >10<span > </span>Citrus
aurantifolia (Christm. & Panz.) Swingle<span > </span>86</p>
<p >11<span > </span>Cleome
gynandra Linn.<span > </span>93</p>
<p >12<span > </span>Curcuma
aromatica Salisb.<span > </span>101</p>
<p >13<span > </span>Datura metel
Linn.<span > </span>110</p>
<p >14<span > </span>Digitalis
purpurea Linn.<span > </span>124</p>
<p >15<span > </span>Ficus
hispida Linn. f.<span > </span>133</p>
<p >16<span > </span>Gloriosa
superba Linn.<span > </span>141</p>
<p >17<span > </span>Gmelina
arborea Roxb.<span > </span>150</p>
<p >18<span > </span>Heracleum
candicans Wall. ex DC.<span > </span>159</p>
<p >19<span > </span>Ipomoea
digitata Linn.<span > </span>168</p>
<p >20<span > </span>Jasminum
auriculatum Vahl<span > </span>176</p>
<p >21<span > </span>Madhuca
indica J.F. Gmel.<span > </span>189</p>
<p >22<span > </span>Myristica
malabarica Lamk.<span > </span>196</p>
<p >23<span > </span>Pterocarpus
marsupium Roxb<span > </span>205</p>
<p >24<span > </span>Pterocarpus
santalinus Linn. f.<span > </span>214</p>
<p >25<span > </span>Rhizophora
mucronata Larnk.<span > </span>224</p>
<p >26<span > </span>Salvadora
persica Linn.<span > </span>232</p>
<p >27<span > </span>Santalum
album Linn.<span > </span>241</p>
<p >28<span > </span>Sarcostemma
acidum (Roxb.) Voigt<span > </span>250</p>
<p >29<span > </span>Sesamum
indicum Linn.<span > </span>259</p>
<p >30<span > </span>Sesbania
sesban (Linn.) Merr.<span > </span>269</p>
<p >31<span > </span>Shorea
robusta Gaertn.<span > </span>282</p>
<p >32<span > </span>Stereospermum
suaveolens (Roxb.) DC.<span > </span>290</p>
<p >33<span > </span>Strychnos
potato rum Linn. f.<span > </span>298</p>
<p >34<span > </span>Terminalia
alata Heyne ex Roth<span > </span>304</p>
<p >35<span > </span>Terminalia
alata Heyne ex Roth<span > </span>315</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluataion
of crude drugs<span > </span>325</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>328</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>333</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>338</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>339</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>341</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>342</p>
<p >II<span > </span>Chemical
constituents<span > </span>344</p>
<p >III<span > </span>Other
names of the plants<span > </span>350</p>
<p ><span > </span></p>
<p ><b >Contents Volume 7<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbrevations<span style='mso-tab-count:
1'> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Contents of' Volume I (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Contents of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Contents of Volume 6 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Alhagi
pseudalhagi (M.Bieb.) Desv.<span > </span>1</p>
<p >2<span > </span>Asclepias
curassavica Linn.<span > </span>13</p>
<p >3<span > </span>Barringtonia
acutangula Gaertn.<span > </span>29</p>
<p >4<span > </span>Caesalpinia
sappan Linn.<span > </span>37</p>
<p >5<span > </span>Costus
speciosus (Koen. ex Retz.) LE. Smith<span > </span>47</p>
<p >6<span > </span>Crinum
asiaticum Linn.<span > </span>56</p>
<p >7<span > </span>Curcuma
zedoaria (Christm.) Rose.<span > </span>67</p>
<p >8<span > </span>Dillenia
indica Linn.<span > </span>78</p>
<p >9<span > </span>Elaeocarpus
sphaericus (Gaertn.) K. Schum.<span > </span>86</p>
<p >10<span > </span>Eucalyptus
globulus Labill.<span > </span>94</p>
<p >11<span > </span>Ficus
benghalensis Linn.<span > </span>104</p>
<p >12<span > </span>Ficus
religiosa Linn.<span > </span>114</p>
<p >13<span > </span>Garcinia
indica (Thouars) Choisy<span > </span>123</p>
<p >14<span > </span>Hygrophila
auriculata (K. Schum.) Heine<span > </span>133</p>
<p >15<span > </span>Illicium g
riffithii Hook.f. & Thoms.<span > </span>142</p>
<p >16<span > </span>Jasminum
grandiflorum Linn.<span > </span>152</p>
<p >17<span > </span>Kaempferia
galanga Linn.<span > </span>162</p>
<p >18<span > </span>Mallotus
philippinensis (Larnk.) Muell.-Arg.<span > </span>171</p>
<p >19<span > </span>Nymphaea
nouchali Burm.f.<span > </span>181</p>
<p >20<span > </span>Nymphaea
pubescens Willd.<span > </span>190</p>
<p >21<span > </span>Piper betle
Linn.<span > </span>198</p>
<p >22<span > </span>Plumbago
indica Linn.<span > </span>208</p>
<p >23<span > </span>Plumbago
zeylanica Linn.<span > </span>218</p>
<p >24<span > </span>Prunus
cerasoides D. Don<span > </span>227</p>
<p >25<span > </span>Sesbania
bispinosa (Jacq.) W. F. Wight<span > </span>235</p>
<p >26<span > </span>Solanum
anguivi Lamk.<span > </span>242</p>
<p >27<span > </span>Solanum
torvum Swartz<span > </span>254</p>
<p >28<span > </span>Solanum
villosum Mill. ssp. villosum Edmonds<span > </span>266</p>
<p >29<span > </span>Spondias
pinnata (Linn.f.) Kurz<span > </span>278</p>
<p >30<span > </span>Stereospermum
suaveolens (Roxb.) DC.<span > </span>286</p>
<p >31<span > </span>Syzygium
cumini (Linn.) Skeels<span > </span>295</p>
<p >32<span > </span>Tamarindus
indica Linn.<span > </span>304</p>
<p >33<span > </span>Vernonia
conyzoides DC.<span > </span>310</p>
<p >34<span > </span>Zizyphus
jujuba Mill.<span > </span>321</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>331</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>334</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>338</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>340</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>341</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>343</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>344</p>
<p >II<span > </span>Chemical
constituents<span > </span>346</p>
<p >III<span > </span>Other
names of the plants<span > </span>353</p>
<p ><span > </span></p>
<p ><b >Contents Volume 8<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknow ledgements<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Contents of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Contents of Volume 6 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Contents of Volume 7 (Plants
covered)<span > </span>XXII</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Abies
spectabilis (D. Don) Mirb.<span > </span>1</p>
<p >2<span > </span>Abrus
precatorius Linn.<span > </span>9</p>
<p >3<span > </span>Aegle
manne/os (Linn.) Correa<span > </span>18</p>
<p >4<span > </span>Aglaia elaeagnoidea
(A. Juss.) Benth.<span > </span>27</p>
<p >5<span > </span>Ammannia
baccifera Linn.<span > </span>36</p>
<p >6<span > </span>Amomum
subulatum Roxb.<span > </span>46</p>
<p >7<span > </span>Andrographis
paniculata (Burm. f.) Wall. ex Nees<span > </span>55</p>
<p >8<span > </span>Angelica
glauca Edgew.<span > </span>68</p>
<p >9<span > </span>Amdirachta
indica A. Juss.<span > </span>77</p>
<p >10<span > </span>Bacopa
monnieri (Linn.) Pennell<span > </span>86</p>
<p >11<span > </span>Buchanania
lanzan Spreng.<span > </span>97</p>
<p >12<span > </span>Butea
monospenna (Lamk.) Taub.<span > </span>105</p>
<p >13<span > </span>Centella
asiatica (Linn.) Urban<span > </span>115</p>
<p >14<span > </span>Centratherum
anthelminticum (Li.nn.) Kuntze<span > </span>128</p>
<p >15<span > </span>Curcuma
longa Linn.<span > </span>138</p>
<p >16<span > </span>Cynodon
dactylon (Linn.) Pers.<span > </span>149</p>
<p >17<span > </span>Emblica
officinalis Gaertn.<span > </span>160</p>
<p >18<span > </span>Exacum
tetragonum Roxb.<span > </span>173</p>
<p >19<span > </span>Helicteres
isora Linn.<span > </span>184</p>
<p >20<span > </span>Holarrhena
pubescens (Buch.-Ham.) Wall. ex G. Don<span > </span>194</p>
<p >21<span > </span>Moringa
oleifera Lamk.<span > </span>203</p>
<p >22<span > </span>Myrica
esculenta Buch.-Ham.<span > </span>211</p>
<p >23<span > </span>Paederia
scandens (Lour.) Merr.<span > </span>220</p>
<p >24<span > </span>Phyllanthus
amarus Schum. & Thonn.<span > </span>232</p>
<p >25<span > </span>Pinus
roxburghii Sargent<span > </span>245</p>
<p >26<span > </span>Piper nigrum
Linn.<span > </span>255</p>
<p >27<span > </span>Pseudarthria
viscida (Linn.) Wight & Am.<span > </span>264</p>
<p >28<span > </span>Rauvolfia
serpentina (Linn.) Benth. ex Kurz<span > </span>272</p>
<p >29<span > </span>Solanum
virginiatum Linn.<span > </span>283</p>
<p >30<span > </span>Sterculia
urens Roxb.<span > </span>296</p>
<p >31<span > </span>Swertia
angustifolia Buch.-Ham. ex D. Don<span > </span>302</p>
<p >32<span > </span>Syzygium
aromaticum (Linn.) Merrill & Perry<span > </span>314</p>
<p >33<span > </span>Tribulus
terrestris Linn.<span > </span>325</p>
<p >34<span > </span>Uraria picta
(Jacq.) Desv. ex DC.<span > </span>339</p>
<p >35<span > </span>Zingiber
officinale Rose.<span > </span>347</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p ><span > </span><span
> </span>Evaluation of crude drugs<span
> </span>359</p>
<p ><span > </span><span
> </span>Phytochemical evaluation of raw
material<span > </span>362</p>
<p ><span > </span><span
> </span>Methods for the isolation of
markers<span > </span>367</p>
<p ><span > </span><span
> </span>Drying and storage of raw material<span
> </span>370</p>
<p ><span > </span><span
> </span>Pesticide residue and microbial
contamination<span > </span>371</p>
<p ><span > </span><span
> </span>Plants allocated to various
institutes<span > </span>373</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p ><span > </span><span
> </span>Botanical names<span
> </span>375</p>
<p ><span > </span><span
> </span>Chemical constituents<span
> </span>377</p>
<p ><span > </span><span
> </span>Other names of the plants<span
> </span>387</p>
<p ><span > </span></p>
<p ><b >Contents Volume 9<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknow ledgements<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Contents of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Contents of Volume 6 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Contents of Volume 7 (Plants
covered)<span > </span>XXII</p>
<p ><span > </span><span
> </span>Contents of Volume 8 (Plants
covered)<span > </span>XXIII</p>
<p ><span > </span><span
> </span>Monographs :<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Acacia
catechu (Linn.f.) Willd.<span > </span>1</p>
<p >2<span > </span>Acacia
nilotica (Linn.) Willd. ex Delile ssp. indica (Benth.) Brenan<span
> </span>10</p>
<p >3<span > </span>Achyranthes
aspera Linn.<span > </span>18</p>
<p >4<span > </span>Aloe vera
(Linn.) Burm.f.<span > </span>32</p>
<p >5<span > </span>Benincasa
hispida (Thunb.) Cogn.<span > </span>47</p>
<p >6<span > </span>Boerhavia
diffusa Linn.<span > </span>59</p>
<p >7<span > </span>1. Cedrus
deodara (Roxb. ex D.Don) G.Don<span > </span>72</p>
<p >8<span > </span>Celastrus
paniculatus Willd.<span > </span>81</p>
<p >9<span > </span>Crocus
sativus Linn.<span > </span>92</p>
<p >10<span > </span>Cuminum
cyminum Linn.<span > </span>101</p>
<p >11<span > </span>Dalbergia
sissoo Roxb.<span > </span>113</p>
<p >12<span > </span>Desmodium
gangeticum (Linn.) DC.<span > </span>122</p>
<p >13<span > </span>Dioscorea
compos ita Hemsl.<span > </span>131</p>
<p >14<span > </span>Eclipta
prostrata (Linn.) Linn.<span > </span>138</p>
<p >15<span > </span>Fagonia
indica Burm.f.<span > </span>152</p>
<p >16<span > </span>Ficus
racemosa Linn.<span > </span>166</p>
<p >17<span > </span>Glycyrrhiia
glabra Linn.<span > </span>175</p>
<p >18<span > </span>Gmelina
arborea Roxb.<span > </span>187</p>
<p >19<span > </span>Hedychium
spicatum Buch.-Ham. ex lE. Smith<span > </span>196</p>
<p >20<span > </span>Hygrophila
auriculata (K. Schum.) Heine<span > </span>205</p>
<p >21<span > </span>Luffa
acutangula (Linn.) Roxb.<span > </span>218</p>
<p >22<span > </span>Melia
azedaracn Linn.<span > </span>234</p>
<p >23<span > </span>Mentha
piperita Linn.<span > </span>242</p>
<p >24<span > </span>Mentha
spicata Linn.<span > </span>253</p>
<p >25<span > </span>Michelia
champaca Linn.<span > </span>262</p>
<p >26<span > </span>Mimosa
pudica Linn.<span > </span>271</p>
<p >27<span > </span>Ocimum
kilimandscharicum Guerke<span > </span>281</p>
<p >28<span > </span>Picrorhiza
kurrooa Royle ex Benth.<span > </span>292</p>
<p >29<span > </span>Rheum
australe D.Don<span > </span>301</p>
<p >30<span > </span>Semecarpus
anacardium Linn.f.<span > </span>311</p>
<p >31<span > </span>Sida
cordifolia Linn.<span > </span>324</p>
<p >32<span > </span>Stevia
rebaudiana (Bertoni) Bertoni<span > </span>333</p>
<p >33<span > </span>Swertia
chirayita (Roxb. ex Fleming) Karsten<span > </span>344</p>
<p >34<span > </span>Withania
somnifera (Linn.) Dunal<span > </span>356</p>
<p >35<span > </span>Zanthoxylum
armatum DC.<span > </span>368</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>379</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>382</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>387</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>389</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>390</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>392</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>394</p>
<p >II<span > </span>Chemical
constituents<span > </span>396</p>
<p >III<span > </span>Other
names of the plants<span > </span>408</p>
<p ><span > </span></p>
<p ><b >Contents Volume 10<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknowledgements<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Contents of Volume 1 (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Contents of Volume 2 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Contents of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Contents of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Contents of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Contents of Volume 6 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Contents of Volume 7 (Plants
covered)<span > </span>XXII</p>
<p ><span > </span><span
> </span>Contents of Volume 8 (Plants
covered)<span > </span>XXIII</p>
<p ><span > </span><span
> </span>Contents of Volume 9 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Monographs :<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Abroma
augusta (Linn.) Linn. f.<span > </span>1</p>
<p >2<span > </span>Acacia
leucophloea (Roxb.) Willd.<span > </span>9</p>
<p >3<span > </span>Aconitum
chasmanthum Stapf. ex Holmes<span > </span>17</p>
<p >4<span > </span>Acorus
calamus Linn.<span > </span>25</p>
<p >5<span > </span>Amomum
subulatum Roxb.<span > </span>38</p>
<p >6<span > </span>Apium
leptophyllum (Pers.) F. Muell. ex Benth.<span > </span>48</p>
<p >7<span > </span>Betula
utilis D. Don<span > </span>59</p>
<p >8<span > </span>Capparis
spinosa Linn. var. spinosa<span > </span>68</p>
<p >9<span > </span>Carthamus
tinctorius Linn.<span > </span>80</p>
<p >10<span > </span>Chenopodium
ambrosioides Linn.<span > </span>91</p>
<p >11<span > </span>Crate va
magna (Lour.) DC.<span > </span>106</p>
<p >12<span > </span>Cucurbita
pepo Linn.<span > </span>116</p>
<p >13<span > </span>Curculigo
orchioides Gaertn.<span > </span>126</p>
<p >14<span > </span>Cyamopsis
tetragonoloba (Linn.) Taub.<span > </span>138</p>
<p >15<span > </span>Cymbopogon
citratus (DC.) Stapf.<span > </span>145</p>
<p >16<span > </span>Datura
stramonium Linn.<span > </span>155</p>
<p >17<span > </span>Derris
indica (Lamk.) Bennet<span > </span>170</p>
<p >18<span > </span>Euphorbia
hirta Linn.<span > </span>180</p>
<p >19<span > </span>Limonia
acidissima Linn.<span > </span>195</p>
<p >20<span > </span>Mammea
suriga (Buch.-Ham. ex Roxb.) Kosterm.<span > </span>205</p>
<p >21<span > </span>Matricaria
chamomilla Linn.<span > </span>215</p>
<p >22<span > </span>Moringa
oleifera Lamk.<span > </span>230</p>
<p >23<span > </span>Nardostachys
jatamansi DC.<span > </span>241</p>
<p >24<span > </span>Ocimum
tenuiflorum Linn.<span > </span>251</p>
<p >25<span > </span>Oroxylum
indicum (Linn.) Vent.<span > </span>261</p>
<p >26<span > </span>Phyla
nodiflora (Linn.) Greene<span > </span>270</p>
<p >27<span > </span>Piper cubeba
Linn. f.<span > </span>282</p>
<p >28<span > </span>Raphanus
sativus Linn.<span > </span>293</p>
<p >29<span > </span>Ricinus
communis Linn.<span > </span>303</p>
<p >30<span > </span>Ruta
chalepensis Linn.<span > </span>326</p>
<p >31<span > </span>Salacia
reticulata Wight<span > </span>334</p>
<p >32<span > </span>Salvadora
persica Linn.<span > </span>343</p>
<p >33<span > </span>Strychnos
nux-vomica Linn.<span > </span>352</p>
<p >34<span > </span>Tridax
procumbens Linn.<span > </span>363</p>
<p >35<span > </span>Vitex
agnus-castus Linn.<span > </span>376</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>387</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>390</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>395</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>401</p>
<p >V<span > </span>Pesticide
residues and microbial contamination<span > </span>402</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>404</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>406</p>
<p >II<span > </span>Chemical
constituents<span > </span>408</p>
<p >III<span > </span>Other
names of the plants<span > </span>423</p>
<p ><span > </span></p>
<p ><b >Contents Volume 11<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknowledgement<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XII</p>
<p ><span > </span><span
> </span>Content of Volume 1 (Plants
covered)<span > </span>XIV</p>
<p ><span > </span><span
> </span>Content of Volume 2 (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Content of Volume 3 (Plants
covered)<span > </span>XVI</p>
<p ><span > </span><span
> </span>Content of Volume 4 (Plants
covered)<span > </span>XVIII</p>
<p ><span > </span><span
> </span>Content of Volume 5 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Content of Volume 6 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Content of Volume 7 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Content of Volume 8 (Plants
covered)<span > </span>XXII</p>
<p ><span > </span><span
> </span>Content of Volume 9 (Plants
covered)<span > </span>XXIII</p>
<p ><span > </span><span
> </span>Content of Volume 10 (Plants
covered)<span > </span>XXIV</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Acacia
pennata (Linn.)Willd.<span > </span>1</p>
<p >2<span > </span>Achyranthes
bidentata Blume<span > </span>12</p>
<p >3<span > </span>Adhatoda
zeylanica Medik<span > </span>25</p>
<p >4<span > </span>Amorphophallus
paeoniifolius (Dennst.) Nicolson<span > </span>38</p>
<p >5<span > </span>Argyreia
nervosa (Burm. F.) Bojer<span > </span>48</p>
<p >6<span > </span>Azadirachta
indica A. Juss. (Flower)<span > </span>58</p>
<p >7<span > </span>Azadirachta
indica A. Juss. (Fruit)<span > </span>68</p>
<p >8<span > </span>Azadirachta
indica A. Juss. (Leaf)<span > </span>83</p>
<p >9<span > </span>Azadirachta
indica A. Juss. (Root bark)<span > </span>98</p>
<p >10<span > </span>Caesalpinia
coriarius (Jacq.) Willd<span > </span>107</p>
<p >11<span > </span>Carthamus
tinctorius Linn<span > </span>116</p>
<p >12<span > </span>Chrysanthemum
indicum Linn<span > </span>125</p>
<p >13<span > </span>Cinnaamomum
zeylanicum Nees (Oil)<span > </span>135</p>
<p >14<span > </span>Citrullus
colocynthis (Linn) Schrad<span > </span>142</p>
<p >15<span > </span>Croton
tiglium Linn<span > </span>151</p>
<p >16<span > </span>Cucumis melo
Linn. Var. utilissimus Duthie & fuller<span > </span>162</p>
<p >17<span > </span>Cucumis
sativus Linn.<span > </span>170</p>
<p >18<span > </span>Dioscorea
bulbifera Linn.<span > </span>179</p>
<p >19<span > </span>Eupatorium
triplinerve vahl<span > </span>190</p>
<p >20<span > </span>Euphorbia
neriifolia Linn<span > </span>202</p>
<p >21<span > </span>Fumaria
indica (Haussk.) Pugsley<span > </span>212</p>
<p >22<span > </span>Gmelina
arborea Roxb.<span > </span>225</p>
<p >23<span > </span>Hibiscus
sabdariffa Linn.<span > </span>234</p>
<p >24<span > </span>Ixora
coccinea Linn.<span > </span>242</p>
<p >25<span > </span>Linum
usitatissmum Linn.<span > </span>253</p>
<p >26<span > </span>Mucuna
pruriens (Linn.) DC.<span > </span>263</p>
<p >27<span > </span>Nerium
indicum Mill.<span > </span>271</p>
<p >28<span > </span>Pavonia
odorata Willd.<span > </span>281</p>
<p >29<span > </span>Pipper
retrofractum Vahl (Fruit)<span > </span>295</p>
<p >30<span > </span>Pipper
retrofractum Vahl (Stem)<span > </span>305</p>
<p >31<span > </span>Plantago
ovata Forssk.<span > </span>315</p>
<p >32<span > </span>Thymus
vulgaris Linn. (Oil)<span > </span>323</p>
<p >33<span > </span>Trianthema
decandra Linn.<span > </span>329</p>
<p >34<span > </span>Vitex
negundo Linn. (Fruit)<span > </span>342</p>
<p >35<span > </span>Vitex
negundo Linn. (Root)<span > </span>356</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>367</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>370</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>376</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>379</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>380</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>382</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>384</p>
<p >II<span > </span>Chemical
constituents<span > </span>386</p>
<p >III<span > </span>Other
names of the plants<span > </span>395</p>
<p ><span > </span></p>
<p ><b >Contents Volume 12<o:p></o:p></b></p>
<p ><span > </span><span
> </span>Foreword<span style='mso-tab-count:
1'> </span>V</p>
<p ><span > </span><span
> </span>Preface<span style='mso-tab-count:
1'> </span>VII</p>
<p ><span > </span><span
> </span>Acknowledgement<span
> </span>VIII</p>
<p ><span > </span><span
> </span>Abbreviations<span
> </span>IX</p>
<p ><span > </span><span
> </span>Introduction<span style='mso-tab-count:
1'> </span>XIII</p>
<p ><span > </span><span
> </span>Content of Volume 1 (Plants
covered)<span > </span>XV</p>
<p ><span > </span><span
> </span>Content of Volume 2 (Plants covered)<span
> </span>XVI</p>
<p ><span > </span><span
> </span>Content of Volume 3 (Plants
covered)<span > </span>XVII</p>
<p ><span > </span><span
> </span>Content of Volume 4 (Plants
covered)<span > </span>XIX</p>
<p ><span > </span><span
> </span>Content of Volume 5 (Plants
covered)<span > </span>XX</p>
<p ><span > </span><span
> </span>Content of Volume 6 (Plants
covered)<span > </span>XXI</p>
<p ><span > </span><span
> </span>Content of Volume 7 (Plants
covered)<span > </span>XXII</p>
<p ><span > </span><span
> </span>Content of Volume 8 (Plants covered)<span
> </span>XXIII</p>
<p ><span > </span><span
> </span>Content of Volume 9 (Plants
covered)<span > </span>XXIV</p>
<p ><span > </span><span
> </span>Content of Volume 10 (Plants
covered)<span > </span>XXV</p>
<p ><span > </span><span
> </span>Content of Volume 11 (Plants
covered)<span > </span>XXVI</p>
<p ><span > </span><span
> </span>Monographs:<span style='mso-tab-count:
1'> </span> </p>
<p >1<span > </span>Abrus
precatorius Linn.<span > </span>1</p>
<p >2<span > </span>Acacia
farnesiana (Linn.) Willd.<span > </span>12</p>
<p >3<span > </span>Acacia
polyacantha Willd.<span > </span>20</p>
<p >4<span > </span>Acalypha
indica Linn.<span > </span>28</p>
<p >5<span > </span>Aconitum
ferox Wall. Ex Ser.<span > </span>41</p>
<p >6<span > </span>Aconitum
violaceum Jacq. Ex stapf.<span > </span>49</p>
<p >7<span > </span>Adiantum
capillus-veneris Linn.<span > </span>57</p>
<p >8<span > </span>Aegle
maemelos (Linn.) Corr. (Root)<span > </span>69</p>
<p >9<span > </span>Aegle
maemelos (Linn.) Corr. (Fruit)<span > </span>79</p>
<p >10<span > </span>Aesculus
hippocastanum Linn.<span > </span>88</p>
<p >11<span > </span>Alpinia
calcarata Rosc.<span > </span>100</p>
<p >12<span > </span>Amaranthus
tricolor Linn.<span > </span>109</p>
<p >13<span > </span>Ananas
comosus (Linn.) Merr.<span > </span>124</p>
<p >14<span > </span>Argemone
mexicana Linn.<span > </span>135</p>
<p >15<span > </span>Buchanania
lanzan Spreng.<span > </span>163</p>
<p >16<span > </span>Carica
papaya Lin.<span > </span>173</p>
<p >17<span > </span>Cassia
fistula Linn.<span > </span>186</p>
<p >18<span > </span>dendrum
phlomidis Linn. F.<span > </span>196</p>
<p >19<span > </span>Derris
indica (Lamk.) Bennet<span > </span>206</p>
<p >20<span > </span>Desmodium
Gangeticum (Linn.) DC.<span > </span>216</p>
<p >21<span > </span>Dryopteris
Filix-mas (Linn.) Schott<span > </span>227</p>
<p >22<span > </span>Eucalyptus
globulus Labill (Oil)<span > </span>237</p>
<p >23<span > </span>Getonia
floribunda Roxb. (Leaf)<span > </span>246</p>
<p >24<span > </span>Getonia
floribunda Roxb. (Root)<span > </span>257</p>
<p >25<span > </span>Glycine max
(Linn.) Merr<span > </span>265</p>
<p >26<span > </span>Heliotropium
indicum Linn.<span > </span>276</p>
<p >27<span > </span>Lepidium
sativum Linn.<span > </span>289</p>
<p >28<span > </span>Leptadenia
reticulata (Retz.) Wight & Arn.<span > </span>299</p>
<p >29<span > </span>Lilium
polyphyllum D. Don ex Royle<span > </span>307</p>
<p >30<span > </span>Manihot
Esculenta Crantz<span > </span>314</p>
<p >31<span > </span>Merremia
tridentata (Linn.) Hall. F.<span > </span>324</p>
<p >32<span > </span>Raphanus sativus
Linn.<span > </span>338</p>
<p >33<span > </span>Sesamum
orientale Linn. (Oil)<span > </span>351</p>
<p >34<span > </span>Sphaeranthus
indicus Linn.<span > </span>363</p>
<p >35<span > </span>Tectona
grandis Linn. F.<span > </span>371</p>
<p ><span > </span><span
> </span>Appendices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Evaluation
of crude drugs<span > </span>383</p>
<p >II<span > </span>Phytochemical
evaluation of raw material<span > </span>386</p>
<p >III<span > </span>Methods
for the isolation of markers<span > </span>394</p>
<p >IV<span > </span>Drying and
storage of raw material<span > </span>398</p>
<p >V<span > </span>Pesticide
residue and microbial contamination<span > </span>399</p>
<p >VI<span > </span>Plants
allocated to various institutes<span > </span>401</p>
<p ><span > </span><span
> </span>Indices<span style='mso-tab-count:
1'> </span> </p>
<p >I<span > </span>Botanical
names<span > </span>403</p>
<p >II<span > </span>Chemical
constituents<span > </span>404</p>
<p >III<span > </span>Other
names of the plants<span > </span>411</p>
<p >IV<span > </span>Monographs published
in earlier volumes (Vols 1-11)<span > </span>416</p>
<p ><o:p> </o:p></p>
<p >Quality Standards of Indian Medicinal Plants</p>
<p >Volume 13</p>
<p >Contents</p>
<p >(<b >Volume 13</b>)</p>
<p >Foreword v</p>
<p >Preface vii</p>
<p >Acknowledgements viii</p>
<p >Abbreviations ix</p>
<p >Introduction xiii</p>
<p >Contents of Volume 1 (Plants covered) xv</p>
<p >Contents of Volume 2 (Plants covered) xvi</p>
<p >Contents of Volume 3 (Plants covered) xvii</p>
<p >Contents of Volume 4 (Plants covered) xix</p>
<p >Contents of Volume 5 (Plants covered) xx</p>
<p >Contents of Volume 6 (Plants covered) xxi</p>
<p >Contents of Volume 7 (Plants covered) xxii</p>
<p >Contents of Volume 8 (Plants covered) xxiii</p>
<p >Contents of Volume 9 (Plants covered) xxiv</p>
<p >Contents of Volume 10 (Plants covered) xxv</p>
<p >Contents of Volume 11 (Plants covered) xxvi</p>
<p >Contents of Volume 12 (Plants covered) xxvii</p>
<p >Monographs :</p>
<p >1. Adhatoda zeylanica Medik. 1</p>
<p >2. Ammi visnaga (Linn.) Lamk. 9</p>
<p >3. Amomum aromaticum Roxb. 19</p>
<p >4. Angelica archangelica Linn. 29</p>
<p >5. Anogeissus latifolia (Roxb. ex DC.) Wall. ex Guill. &
Perr. 39</p>
<p >6. Apium graveolens Linn. 48 </p>
<p >7. Artocarpus heterophyllus Lamk. 63</p>
<p >8. Atropa belladonna Linn. 81</p>
<p >9. Baliospermum montanum (Willd.) Muell.-Arg. (Leaf) 91</p>
<p >10. Baliospermum montanum (Willd.) Muell.-Arg. (Root) 102</p>
<p >11. Bambusa bambos (Linn.) Voss 110</p>
<p >12. Bauhinia vahlii Wight & Arn. 119</p>
<p >13. Brassica campestris Linn. 128</p>
<p >14. Butea monosperma (Lamk.) Taub. 137</p>
<p >15. Cajanus cajan (Linn.) Millsp. (Seed) 146</p>
<p >16. Cajanus cajan (Linn.) Millsp. (Root) 156</p>
<p >17. Calophyllum inophyllum Linn. (Oil) 165</p>
<p >18. Calotropis procera (Ait.) Dryand. ssp. hamiltonii
(Wight) Ali (Stem bark) 172</p>
<p >19. Calotropis procera (Ait.) Dryand. ssp. hamiltonii
(Wight) Ali (Root) 179</p>
<p >20. Carissa carandas Linn. 188</p>
<p >21. Cichorium intybus Linn.(Leaf) 197</p>
<p >22. Cichorium intybus Linn. (Fruit) 205</p>
<p >23. Coriandrum sativum Linn. 214</p>
<p >24. Cymbopogon martini (Roxb.) W. Wats. 224</p>
<p >25. Datura metel Linn. 236</p>
<p >26. Ficus benghalensis Linn. 244</p>
<p >27. Foeniculum vulgare (Linn.) Mill. 254</p>
<p >28. Gaultheria fragrantissima Wall. (Oil) 264</p>
<p >29. Litsea glutinosa (Lour.) C.B. Rob. 269</p>
<p >30. Mangifera indica Linn. 278</p>
<p >31. Pandanus odoratissimus Linn.f. 290</p>
<p >32. Portulaca oleracea Linn. 299</p>
<p >33. Rosa × centifolia Linn. 313</p>
<p >34. Sphaeranthus indicus Linn. 323</p>
<p >35. Viola odorata Linn. 330</p>
<p >33. Rosa × centifolia Linn. 313</p>
<p >34. Sphaeranthus indicus Linn. 323</p>
<p >35. Viola odorata Linn. 330</p>
<p >Appendices</p>
<p >I. Evaluation of crude drugs 345</p>
<p >II. Phytochemical evaluation of raw material 348</p>
<p >III. Methods for the isolation of markers 354</p>
<p >IV. Drying and storage of raw material 358</p>
<p >V. Pesticide residue and microbial contamination 359</p>
<p >VI. Plants allocated to various institutes 361</p>
<p >Indices</p>
<p >I. Botanical names 363</p>
<p >II. Chemical constituents 365</p>
<p >III. Other names of the plants 373</p>
<p >IV. Monographs published in earlier volumes (Vols 1-12) 380</p>